| 1. |
Terasaki M, Shibui S, Narita Y, Fujimaki T, Aoki T, Kajiwara K, Sawamura Y, Kurisu K, Mineta T, Yamada A, Itoh K. Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen--A24 with recurrent or progressive glioblastoma multiforme. J Clin Oncol. 2011 Jan 20; 29(3): 337-44. Epub 2010 Dec 13. |
| 2. |
Sekine I, Kubota K, Tamura Y, Asahina H, Yamada K, Horinouchi H, Nokihara H, Yamamoto N, Tamura T. Innovator and generic cisplatin formulations: comparison of renal toxicity. Cancer Sci. 2011 Jan; 102(1): 162-5. doi: 10. 1111/j. 1349-7006. 2010. 01764.x. Epub 2010 Nov 5. |
| 3. |
Mitsui Y, Gotoh M, Fukushima N, Shirachi I, Otabe S, Yuan X, Hashinaga T, Wada N, Mitsui A, Yoshida T, Yoshida S, Yamada K, Nagata K. Hyperadiponectinemia enhances bone formation in mice. BMC Musculoskelet Disord. 2011 Jan 17; 12: 18. |
| 4. |
Imamura Y, Azuma K, Kurata S, Hattori S, Sasada T, Kinoshita T, Okamoto M, Kawayama T, Kaida H, Ishibashi M, Aizawa H. Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy. Lung Cancer. 2011 Jan; 71(1): 49-54. Epub 2010 Apr 28. |
| 5. |
Hirotoshi Kobayashi, Hidetaka Mochizuki, Takayuki Morita, Kenjiro Kotake, Tatsuo Teramoto, Shingo Kameoka, Yukio Saito, Keiichi Takahashi, Kazuo Hase, Masatoshi Oya, Koutarou Maeda, Takashi Hirai, Masao Kameyama, Kazuo Shirouzu, Kenichi Sugihara. Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study. J Gastroenterol. 2011 Feb; 46(2): 203-11. Epub 2010 Dec 9. |
| 6. |
Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, Yamaguchi T, Ono M, Sakaguchi S, Matsuoka M. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011 Feb 10; 7(2): e1001274. |
| 7. |
Hagiya K, Yasunaga J, Satou Y, Ohshima K, Matsuoka M.. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells. Retrovirology. 2011 Mar 17; 8: 19. |
| 8. |
Azuma K, Tsurutani J, Sakai K, Kaneda H, Fujisaka Y, Takeda M, Watatani M, Arao T, Satoh T, Okamoto I, Kurata T, Nishio K, Nakagawa K. Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure. Biochem Biophys Res Commun. 2011 Apr 1; 407(1): 219-24. Epub 2011 Mar 4. |
| 9. |
Yamada K, Yamamoto N, Yamada Y, Nokihara H, Fujiwara Y, Hirata T, Koizumi F, Nishio K, Koyama N, Tamura T. Phase I dose-escalation study and biomarker analysis of E7080 in patients with advanced solid tumors. Clin Cancer Res. 2011 Apr 15; 17(8): 2528-37. Epub 2011 Mar 3. |
| 10. |
Terasaki M, Eto T, Nakashima S, Okada Y, Ogo E, Sugita Y, Tokutomi T, Shigemori M. A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme. 2011 Apr; 102(2): 247-53. Epub 2010 Jul 17. |
| 11. |
Terasaki M, Sugita Y, Arakawa F, Okada Y, Ohshima K, Shigemori M. CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target. Brain Tumor Pathol. 2011 Apr; 28(2): 89-97. Epub 2011 Jan 6. |
| 12. |
Fujimoto K, Kawaguchi T, Nakashima O, Ono J, Ohta S, Kawaguchi A, Tonan T, Ohshima K, Yano H, Hayabuchi N, Izuhara K, Sata M. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma. Oncol Rep. 2011 May; 25(5): 1211-6. |
| 13. |
Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Kawayama T, Fujimoto K, Ohshima K, Shiraishi H, Uchida M, Ono J, Ohta S, Kato S, Izuhara K, Aizawa H. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J. 2011 May; 37(5): 1119-27. |
| 14. |
Niino D, Ohsaki K, Arakawa F, Watanabe J, Kimura Y, Kiyasu J, Takeuchi M, Miyoshi H, Yoshida M, Sugita Y, Ohshima K, Okamura T. Composite T lymphoblastic leukemia/lymphoma and diffuse large B-cell lymphoma: case report. Pathol Int. 2011 Jun; 61(6): 363-8. |
| 15. |
Naito Y, Okabe Y, Nagayama M, Nishinakagawa T, Taira T, Kawahara A, Hattori S, Machida K, Ishida Y, Kaji R, Mikagi K, Kinoshita H, Yasumoto M, Akiba J, Kage M, Nakashima M, Ohshima K, Yano H. Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice. Med Mol Morphol. 2011 Jun; 44(2): 86-92. |
| 16. |
Shiratsuchi I, Akagi Y, Kawahara A, Kinugasa T, Romeo K, Yoshida T, Ryu Y, Gotanda Y, Kage M, Shirouzu K. Expression of IGF-1 and IGF-1R and their relation to clinicopathological factors in colorectal cancer. Anticancer research 2011 Jul;31(7):2541-5. |
| 17. |
Shimizu-Kohno K, Satou Y, Arakawa F, Kiyasu J, Kimura Y, Niino D, Sugita Y, Ishikawa F, Matsuoka M, Ohshima K. Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues. Cancer Sci. 2011 Jul; 102(7): 1432-6. |
| 18. |
Katouda M, Soejima T, Kanazawa T, Tabuchi K, Yamaki K, Nagata K. Relationship between thickness of the anteromedial bundle and thickness of the posterolateral bundle in the normal ACL. Knee Surg Sports Traumatol Arthrosc. 2011 Aug; 19(8) : 1293-8. |
| 19. |
Tanioka M, Nokihara H, Yamamoto N, Yamada Y, Yamada K, Goto Y, Fujimoto T, Sekiguchi R, Uenaka K, Callies S, Tamura T. Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors.Cancer Chemother Pharmacol. 2011 Aug; 68(2): 505-11. Epub 2010 Nov 16. |
| 20. |
Kimura Y, Imamura Y, Higaki K, Ohno Y, Hashiguchi N, Seki R, Okamura T, Arakawa F, Kiyasu J, Takeuchi M, Miyoshi H, Yoshida M, Nakamura Y, Niino D, Sugita Y, Ohshima K. Case of polycythemia vera with unusual organizing pneumonia mimicking the clinical features of military tuberculosis and possibly caused by the involvement of neoplastic megakaryocytes. Pathol Int. 2011 Aug;61(8):486-90. |
| 21. |
Pongpruttipan T, Kummalue T, Bedavanija A, Khuhapinant A, Ohshima K, Arakawa F, Niino D, Sukpanichnant S. Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand. Diagn Pathol. 2011 Aug 25; 6: 79 |
| 22. |
Azuma K, Okamoto I, Kawahara A, Taira T, Nakashima K, Hattori S, Kinoshita T, Takeda M, Nakagawa K, Takamori S, Kuwano M, Ono M, Kage M. Association of the Expression of Mutant Epidermal Growth Factor Receptor Protein as Determined with Mutation-Specific Antibodies in Non-small Cell Lung Cancer with Progression-Free Survival after Gefitinib Treatment. Journal of thoracic oncology . 2011 Sep 1. |
| 23. |
Kimura Y, Sato K, Imamura Y, Arakawa F, Kiyasu J, Takeuchi M, Miyoshi H, Yoshida M, Niino D, Sugita Y, Morito T, Yoshino T, Nakamura S, Ohshima K. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index.Cancer Sci. 2011 Sep; 102(9): 1734-41. |
| 24. |
Hamabashiri M, Daichou A, Yasumoto M, Ogasawara S, Nishinakagawa T, Enjoji M, Ohshima K, Yano H,Nakashima M. Novel monoclonal antibodies against pancreatic juice from pancreatic cancer patients and their possible application in differential diagnosis. Int J Mol Med. 2011 Oct; 28(4): 599-603. |
| 25. |
Baba K, Ishibashi M, Kaida H, Fujii T, Hiromatsu Y, Kawahara A, Kage M, Hayabuchi N. Relation between (99m)Tc-tetrofosmin thyroid scintigraphy and mitogen-activated protein kinase in papillary thyroid cancer patients. Japanese Journal of Radiology . 2011 Oct;29(8):533-9. |
| 26. |
Takahashi E, Ohshima K, Kimura H, Hara K, Suzuki R, Kawa K, Eimoto T, Nakamura S; for the NK-cell Tumor Study Group. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders. Histopathology. 2011 Oct; 59(4): 660-671. |
| 27. |
Asano N, Kinoshita T, Tamaru J, Ohshima K, Yoshino T, Niitsu N, Tsukamoto N, Hirabayashi K, Izutsu K, Taniwaki M, Morishima Y, Nakamura S. Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type. Haematologica. 2011 Nov; 96(11): 1636-43. |
| 28. |
Yamaguchi R, Tsuchiya SI, Koshikawa T, Yokoyama T, Mibuchi K, Nonaka Y, Ito S, Higuchi H, Nagao M, Watanabe J, Higaki K, Kage M, Yano H. Comparison of the Accuracy of Breast Cytological Diagnosis at Seven Institutions in Southern Fukuoka Prefecture, Japan. Japanese journal of clinical oncology. 2011 Nov 22. [Epub ahead of print] |
| 29. |
Kawaguchi T, Kaji R, Horiuchi H, Shirono T, Ishida Y, Okabe Y, Itou M, Mitsuyama K, Akiba J, Nakashima O, Yano H, Kage M, Harada M, Sakisaka S, Sata M. Development of intrahepatic cholangiocarcinoma after a 14-year follow-up of a patient with primary sclerosing cholangitis and ulcerative colitis. Hepatology research. 2011 Dec;41(12):1253-1259. |
| 30. |
Ushijima K. Hormoral therapy for endometrial carcinoma of uterus. Chemotherapeutic strategies for gynecological cancers. 2011; 79-91. |
| 31. |
Kawano K，Ushijima K，Yokomine M，Fukui A，Ijichi M，Kamura T. A case of minimal uterine serous carcinoma with distant lymph node metastasis without peritoneal dissemination. J Gynecol Oncol. 2011; 22: 1-4. |
| 32. |
Matsugaki T, Shiba N, Kohno S, Nikawa T, Hirasaka K, Okumura Y, Ishidoh K, Soejima T, Yoshimitsu K, Nagata K. "Hybrid exercise" prevents muscle atrophy in association with a distinct gene expression pattern. Kurume Med J. 2011; 57(4): 101-8. |
| 33. |
Toshiaki Tanaka, Satoru Matono, Takeshi Nagano, Kazutaka Murata, Susumu Sueyoshi, Hideaki Yamana, Kazuo Shirouzu, Hiromasa Fujita. Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus. Gastrointestinal Endoscopy. 2011; 73(1): 1-6. Epub 2010 Nov 12. |
| 34. |
Hirotoshi Kobayashi, Hidetaka Mochizuki, Takayuki Morita, Kenjiro Kotake, Tatuo Teramoto, Shingo Kameoka, Yukio Saito, Keiichi Takahashi, Kazuo Hase, Masatoshi Oya, Koutarou Maeda, Takashi Hirai, Masao Kameyama, Kazuo Shirouzu, Kenichi Sugihara. Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multiceter study. J Gastroenterol Springer. 2011; 46: 203-211. |
| 35. |
Yutaka Ogata, Shoji Tokunaga, Yasunori Emi, Eiji Oki, Hiroshi Saeki, Ken Shirabe, Hirofumi Hasegawa, Noriaki Sadanaga, Hironori Samura, Fumihiko Fujita, Takaho Tanaka, Masaki Kitazono, Manabu Yamamoto, Tatsuma Morikita, Masafumi Inomata, Yoshihiro Kakeji, Kazuo Shirouzu, Yoshihiko Maehara. A Multicenter Phase II Clinical Study of Oxaliplatin, Folinic Acid, and 5-Fluorouracil Combination Chemotherapy as Second-Line Treatment for Advanced Colorectal Cancer: A Japanese Experience. Kyushu Study Group of Clinical Cancer(KSCC). Surgery Today. Springer. 2011; 41: 84-90. |
| 36. |
Yoshinori Nagamatu, Yasunori Iwasaki, Masaki Kashihara, Tatuya Noshi, Koichi Yoshiyama, Hideaki Yamana, Kazuo Shirouzu. Selection of Pulmonary Resection Procedures to Reduce Postoperative Complications in 200 Patients. Surgery Today. Springer. 2011; 41: 780-786. |
| 37. |
Hideki Ueno, Hidetaka Mochizuki, Kazuo Shirouzu, Takaya Kusumi, Kazutaka Yamada, Masahiro Ikegami, Hiroshi Kawachi, Shingo Kameoka, Yasuo Ohkura, Tadahiko Masaki, Ryoji Kushima, Keiichi Takahashi, Yoichi Ajioka, Kazuo Hase, Atsushi Ochiai, Ryo Wada, Keiichi Iwaya, Takahiro Nakamura, Kenichi Sugihara. Actual Status of Distribution and Prognostic Impact of Extramural Discontinuous Cancer Spread in Colorectal Cancer. Journal of Clinical Oncology. 2011; 29(18): 2550-2556. |
| 38. |
Ichitarou Shiratsuchi, Yoshito Akagi, Akihiko Kawahara, Tetsushi Kinugasa, Kansakar Romeo, Takefumi Yoshida, Yasuhiko Ryu, Yukito Gotanda, Masayoshi Kage, Kazuo Shirouzu. Expression of IGF-1 and IGF-1R and Their Relation to Clinicopathological Factors in Colorectal Cancer. Anticancer Research. 2011; 31: 2541-2546. |
| 39. |
Kazuo Shirouzu, Yoshito Akagi, Shin Fujita, Hideki Ueno, Yasumasa Takii, Koji Komori, Masaaki Ito, Kenichi Sugihara. Clinical Significance of the Mesorectal Extension of Rectal Cancer: A Japanese Multi-institutional Study. (JSCCR). Annals of Surgery. 2011; 253(4): 704-710. |
| 40. |
Takefumi Yoshida, Tetsushi Kinugasa, Yoshito Akagi, Akihito Kawahara, Kansakar Romeo, Ichitarou Shiratsuchi, Yasuhiko Ryu, Yukito Gotanda, Kazuo Shirouzu. Decreased Expression of Claudin-1 in Rectal Cancer: A Factor for Recurrence and Poor Prognosis. Anticancer Research. 2011; 31: 2517-2526. |
| 41. |
Tetsushi Kinugasa, Yoshito Akagi, Kenta Murotani, Kansakar Romeo, Takefumi Yoshida, Yasuhiko Ryu, Ichitarou Shiratsuchi, Kazuo Shirouzu. Relationship between Ulcerative Colitis Patients Treated with eukocytapheresis and Uicerative Colitis-associated Colorectal Cancer. Anticancer Research. 2011; 31: 2547-2552. |
| 42. |
Muta F, Takamori S, Matsuo T, Iwasaki Y, Yoshiyama K, Shirouzu K. Changes in the pleural cavity by pleurodesis using talc or OK-432: An experimental study. Surg Today. 2011; 41(1):111-114. |
| 43. |
Satoru Matono, Hiromasa Fujita, Toshiaki Tanaka, Yuichi Tanaka, Takeshi Nagano, Kohei Nishimura, Kazutaka Murata, Susumu Sueyoshi, Kazuo Shirouzu. Esophagectomy for Thoracic Esophageal Cancer with a Double Aortic Arch: Report of a Case. Surgery Todar Springer. 2011; 41: 1150-1155. |
| 44. |
Hirotoshi Kobayashi, Hidetaka Mochizuki, Tomoyuki Kato, Takeo Mori, Shingo Kameoka, Kazuo Shirouzu, Yukio Saito, Masahiko Watanabe, Takayuki Morita, Jin-ichi Hida, Masashi Ueno, Masato Ono, Masamichi Yasuno, Kenichi Sugihara. Study Group for Rectal cancer surgery of the Japanese Society for Cancer of the Colon and Rectum Lymph node ratio is a powerful prognostic index in patients with stage Ⅲ distal rectal rectal cancer: a Japanese multicenter study. Int J Colorectal Springer. 2011; 26: 891-896. |
| 45. |
Yoshinori Nagamatsu, Yasunori Iwasaki, Ryozo Hayashida, Masaki Kashihara, Tatsuya Nishi, Koichi Yoshiyama, hideaki Yamana, Kazuo Shirouzu. Factors Related to an Early Restoration of Exercise Capacity After Major Lung Resection. Suger Today. 2011; 41: 1228-1233. |
| 46. |
Hiromasa Fujita, Yuko Kitagawa. The Japan Esophageal Socienty Consensus Meeting 2010. Esophagus Springer. 2011; 8: 159-167. |
| 47. |
Naito Y, Okabe Y, Nagayama M, Nishinakagawa T, Taira T, Kawahara A, Hattori S, Machida K, Ishida Y, Kaji R, Mikagi K, Kinoshita H, Yasumoto M, Akiba J, Kage M, Nakashima M, Ohshima K, Yano H. Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice. Med Mol Morphol. 2011; 44(2): 86-92. |
| 48. |
Kaida H, Hiromatsu Y, Kurata S, Kawahara A, Hattori S, Taira T, Kobayashi M, Uchida M, Yamada K, Mihashi H, Umeno H, Kage M, Nakashima T, Hayabuchi N, Ishibashi M. Relationship between clinicopathological factors and fluorine-18-fluorodeoxyglucose uptake in patients with papillary thyroid cancer. Nucl Med Commun. 2011; 32(8): 690-8. |
| 49. |
Mizuochi T, Kimura A, Nishiura H, Inomata Y, Okajima H, Sugie H, Mitsubuchi H, Yagi M, Kage M. Liver biopsy is an important procedure in the diagnosis of glycogen storage disease type IV. Pediatr Int. 2011; 53(1): 129-30. |
| 50. |
Kawahara A, Harada H, Abe H, Yamaguchi T, Taira T, Nakashima K, Mihashi H, Akiba J, Kage M. Nuclear β-catenin expression in basal cell adenomas of salivary gland. J Oral Pathol Med. 2011; 40(6): 460-6. |
| 51. |
Aikawa E, Kawahara A, Kondo K, Hattori S, Kage M. Morphometric analysis and p63 improve the identification of myoepithelial cells in breast lesion cytology. Diagn Cytopathol. 2011; 39(3): 172-6. |
|---|
| 52. |
Fujimoto K, Tonan T, Azuma S, Kage M, Nakashima O, Johkoh T, Hayabuchi N, Okuda K, Kawaguchi T, Sata M, Qayyum A. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. Radiology. 2011; 258(3): 739-48. |
|---|
| 53. |
Shirachi I, Gotoh M, Mitsui Y, Yamada T, Nakama K, Kojima K, Okawa T, Higuchi F, Nagata K. Collagen Production at the Edge of Ruptured Rotator Cuff Tendon is Correlated With Postoperative Cuff Integrity. Arthroscopy. 2011 Jul 11(in press). |
|---|
| 54. |
Fujii T, Takahashi H, Inoue Y, Kage M, Yamana H, Shirouzu K. Preclinical and clinical developments in molecular-targeting therapeutic strategies for breast cancer. Breast Cancer Cells / Book 5, InTech, 2011 (in press). |
|---|
| 55. |
Takemoto S，Ushijima K，Honda K，Wada H，Terada A，Imaishi H，Kamura T. Precise evaluation of chemotherapy - induced peripheral neuropathy using the visual analogue scale : a quantitative and comparative analysis of neuropathy occurring with paclitaxel - carboplatin and docetaxel - carboplatin therapy. Int J Clin Oncol.2011; (in press). |
|---|
| 56. |
Ushijima K，Kamura T，Tamura K，Kuzuya K，Sugiyama T，Noda K，Ochiai K. Docetaxel / Irinotecan combination chemotherapy in platinum / taxan refractory and resistant ovarian cancer ? JGOG / WJGOG intergroup study-. Int J Clin Oncol. 2011; (in press). |
|---|
| 57. |
Sharma P, Iwakuma N, Brown S, Singh A, Knapik J, Moudgil B, Grobmyer S.R. “Infrared Absorbing and Luminescent Gold Speckled Silica Nanoparticles for Photothermal Therapy.” Journal of Materials Chemistry. 2011 (in press). |
|---|
| 58. |
Azuma K, Okamoto I, Kawahara A, Hattori S, Taira T, Nakashima K, Takamori S, Nakagawa K. Kage M, Kuwano M, Ono M. Association of the expression of mutant EGFR protein as determined with mutation-specific antibodies in non?small cell lung cancer with progression-free survival after gefitinib treatment. J Thorac Oncol. 2011 (in press). |
|---|
| 59. |
Kawahara A, Azuma K, Sumi A, Taira T, Nakashima K, Aikawa E, Abe H, Yamaguchi T, Takamori S, Akiba J, Kage M. Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: Rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry. Lung Cancer. 2011 Mar 26(in press). |
|---|
| 60. |
Aikawa E, Kawahara A, Hattori S, Yamaguchi T, Abe H, Taira T, Azuma K, Kage M. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings. Cancer Cytopathol. 2011 Jun 29. doi: 10. 1002/cncy. 20162. |
|---|
| 61. |
Akiba J, Murakami Y, Noda M, Watari K, Ogasawara S, Yoshida T, Kawahara A, Sanada S, Yasumoto M, Yamaguchi R, Kage M, Kuwano M, Ono M, Yano H. N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G(0)/G(1) phase. Cancer Lett. 2011( in press). |
|---|
| 62. |
Nomura Y, Naito Y, Eriguchi N, Kume T, Itai N, Sonoda H, Hayashida S, Naito S, Naito H, Yasumoto M, Akiba J, Kinoshita H, Yano H, Kage M. A case of IgG4-related sclerosing mesenteritis. Pathol Res Pract. 2011( in press). |
|---|
| 63. |
Taira T, Kawahara A, Yamaguchi T, Abe H, Ishida Y, Okabe Y, Naito Y, Yano H, Kage M. Morphometric image analysis of pancreatic disease by ThinPrep liquid-based cytology. Diagn Cytopathol. 2011( in press). |
|---|
| 64. |
Abe H, Kawahara A, Sugita Y, Yamaguchi T, Terasaki M, Kage M. Follow-up evaluation of radiation-induced DNA damage in CSF disseminated high-grade glioma using phospho-histone H2AX antibody. Diagn Cytopathol. 2011( in press). |
|---|
| 65. |
Naito Y, Okabe Y, Kawahara A, Taira T, Yamaguchi T, Abe H, Arikawa S, Nakayama M, Yasumoto M, Eriguchi N, Naito H, Kage M, Yano H. Guide to diagnosing primary pancreatic lymphoma, B-cell type: Immunocytochemistry improves the diagnostic accuracy of endoscopic ultrasonography-guided fine needle aspiration cytology. Diagn Cytopathol. 2011( in press). |
|---|
| 66. |
Yamaguchi R, Tanaka M, Yokoyama T, Nonaka Y, Mizushima Y, Kawahara A, Yoshida T, Ito T, Yamaguchi M, Kage M, Yano H. Cytological features of myxomatous fibroadenoma of the breast. Diagn Cytopathol. 2011( in press). |
|---|
| 67. |
Fotovati A, Abu-Ali S, Kage M, Shirouzu K, Yamana H, Kuwano M. N-myc Downstream-regulated Gene 1 (NDRG1) a Differentiation Marker of Human Breast Cancer. Pathol Oncol Res. 2011( in press). |
|---|
| 68. |
Sato H, Oka T, Shinnou Y, Kondo T, Washio K, Takano M, Takata K, Morito T, Huang X, Tamura M, Kitamura Y, Ohara N, Ouchida M, Ohshima K, Shimizu K, Tanimoto M, Takahashi K, Matsuoka M, Utsunomiya A, Yoshino T. Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma. Am J Pathol. 2010 Jan; 176(1): 402-15. |
|---|
| 69. |
Yoshimitsu K, Shiba N, Matsuse H, Takano Y, Matsugaki T, Inada T, Tagawa Y, Nagata K. Development of a training method for weightless environment using both electrical stimulation and voluntary muscle contraction. Tohoku J Exp Med. 2010 Jan; 220(1): 83-93. |
|---|
| 70. |
Yamada K, Nakao M, Fukuyama C, Nokihara H, Yamamoto N, Sekine I, Kunitoh H, Ohe Y, Ohki E, Hashimoto J, Tamura T. Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer. Cancer Sci. 2010 Jan; 101(1): 188-95. Epub 2009 Sep 14. |
|---|
| 71. |
H. Fujita, S. Ozawa, H. Kuwano, Y. Ueda, S. Hattori, T. Yanagawa. Esophagectomy for cancer: Clinical concerns support centralizing operations within the larger hospitals. Dis Esophagus. 2010 Feb; 23(2): 145-52. Epub 2009 Jun 9. |
|---|
| 72. |
Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K, Nakamura S, Inagaki H, Ohshima K, Kiyoi H, Ishida T, Matsushima K, Akinaga S, Ogura M, Tomonaga M, Ueda R. Phase I study of KW-0761 ,a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol. 2010 Mar 20; 28(9): 1591-8. |
|---|
| 73. |
Shimoyama T, Hiraoka K, Shoda T, Hamada T, Fukushima N, Nagata K. Multicentric extra-abdominal desmoid tumors arising in bilateral lower limbs. Rare Tumors. 2010 Mar 31; 2(1): e12. |
|---|
| 74. |
Asano N, Suzuki R, Ohshima K, Kagami Y, Ishida F, Yoshino T, Ogawa H,Morishima Y, Nakamura S. Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in Peripheral T cell lymphoma, not otherwise specified and ALK ? negative anaplastic large cell Lymphoma. Int J Hematol. 2010 Apr; 91(3): 426-35. |
|---|
| 75. |
Niino D, Komohara Y, Murayama T, Aoki R, Kimura Y, Hashikawa K, Kiyasu J, Takeuchi M, Suefuji N, Sugita Y, Takeya M, Ohshima K. Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL). Pathol Int. 2010 Apr; 60(4): 278-83. |
|---|
| 76. |
Kimura Y, Sugita Y, Seki R, Inada H, Arakawa F, Kiyasu J, Takeuchi M, Hashikawa K, Aoki R, Niino D, Ohshima K. Infant juvenile myelomonocytic leukemia (JMML) with rapid infiltration of multiple organs. Pathol Int. 2010 Apr; 60(4): 333-5. |
|---|
| 77. |
Nakama K, Gotoh M, Mitsui Y, Shirachi I, Higuchi F, Nagata K. Use of autologous fibrin sealants to treat ganglion cysts: a report of two cases. J Orthop Surg (Hong Kong). 2010 Apr; 18(1): 104-6. |
|---|
| 78. |
Sato I, Higuchi A, Yanagisawa T, Mukasa A, Ida K, Sawamura Y, Sugiyama K, Saito N, Kumabe T, Terasaki M, Nishikawa R, Ishida Y, Kamibeppu K. Development of the Japanese version of the Pediatric Quality of Life Inventory Brain Tumor Module. Health Qual Life Outcomes. 2010 Apr 14; 8: 38. |
|---|
| 79. |
Yagi M, Sato N, Mitsui Y, Gotoh M, Hamada T, Nagata K. J Hyaluronan modulates proliferation and migration of rabbit fibroblasts derived from flexor tendon epitenon and endotenon. Hand Surg Am. 2010 May; 35(5): 791-6. |
|---|
| 80. |
Yamada K, Yamamoto N, Yamada Y, Mukohara T, Minami H, Tamura T. Phase I and pharmacokinetic study of ABI-007, albumin-bound paclitaxel, administered every 3 weeks in Japanese patients with solid tumors. Jpn J Clin Oncol. 2010 May; 40(5): 404-11. Epub. 2010 Feb 4. |
|---|
| 81. |
Nago M, Mitsui Y, Gotoh M, Nakama K, Shirachi I, Higuchi F, Nagata K. Hyaluronan modulates cell proliferation and mRNA expression of adhesion-related procollagens and cytokines in glenohumeral synovial/capsular fibroblasts in adhesive capsulitis. J Orthop Res. 2010 Jun; 28(6):726-31. |
|---|
| 82. |
Kawahara A, Yamamoto C, Nakashima K, Azuma K, Hattori S, Kashihara M, Aizawa H, Basaki Y, Kuwano M, Kage M, Mitsudomi T, Ono M. Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysis. Clin Cancer Res. 2010 Jun 15; 16(12): 3163-70. |
|---|
| 83. |
Niino D, Yamamoto K, Tsuruta O, Maeda T, Yakushijin Y, Aoki R, Kimura Y, Hashikawa K, Kiyasu J, Takeuchi M, Sugita Y, Ohshima K. Regression of rectal mucosa-associated lymphoid tissue (MALT) lymphoma after antibiotic treatments. Pathol Int. 2010 Jun; 60(6): 438-42. |
|---|
| 84. |
Kawahara A, Azuma K, Hattori S, Nakashima K, Basaki Y, Akiba J, Takamori S, Aizawa H, Yanagawa T, Izumi H, Kohno K, Kono S, Kage M, Kuwano M, Ono M. The close correlation between 8-hydroxy-2'-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer. Hum Pathol. 2010 Jul; 41(7): 951-9. Epub 2010 Mar 17. |
|---|
| 85. |
Yoshimura J, Fukami K, Koike K, Nagano M, Matsumoto T, Iwatani R, Kusumoto T, Hazama T, Ueda S, Adachi H, Hirai Y, Takasu K, Ohshima K, Yamagishi S, Okuda S. Interstitial Foxp3-positive T cells may predict renal survival in patients withmyeroperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Bv bClin Exp Pharmacol Physiol. 2010 Sep; 37(9): 879-83. Epub 2010 May 28. |
|---|
| 86. |
Fukushima N, Hiraoka K, Shirachi I, Kojima K, Nagata K. Isolation and characterization of a novel peptide, osteoblast activating peptide (OBAP), associated with osteoblast differentiation and bone formation. Biochem Biophys Res Commun. 2010 Sep 10; 400(1):157-63. |
|---|
| 87. |
Matsugaki T, Zenmyo M, Hiraoka K, Fukushima N, Shoda T, Komiya S, Ono M, Kuwano M, Nagata K. N-myc downstream-regulated gene 1/Cap43 expression promotes cell differentiation of human osteosarcoma cells. Oncol Rep. 2010 Sep; 24(3): 721-5. |
|---|
| 88. |
Krishna, V., Singh, A., Sharma, P., Iwakuma, N., Wang, Q., Zhang, Q., Knapik, J., Jiang, H., Grobmyer, S.R., Koopman, B., Moudgil, B. “Polyhydroxyl Fullerenes for Non-Invasive Cancer Imaging and Therapy. Small. 2010 Oct 18; 6(20): 2236-41. |
|---|
| 89. |
Fujisaka Y, Yamada Y, Yamamoto N, Shimizu T, Fujiwara Y, Yamada K, Tamura T, Watanabe H, Sun YN, Bass MB, Seki M. Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors. Cancer Chemother Pharmacol. 2010 Oct; 66(5): 935-43. Epub 2010 Jan 28. |
|---|
| 90. |
Kitasato Y, Yasunaga M, Goto Y, Sato T, Akasu G, Shiota K, Sakai H, Ogata T, Okuda K, Kinoshita H, Shirouzu K, Aoyagi S. Laparoscopic radiofrequency ablation for hepatocellular carcinoma. Gan To Kagaku Ryoho. 2010 Nov; 37(12): 2662-3. |
|---|
| 91. |
Sugita Y, Terasaki M, Niino D, Ohshima K, Fumiko A, Shigemori M, Sato Y, Asano N. Epstein-Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing. J Neurooncol. 2010 Nov; 100(2): 271-9. Epub 2010 May 9. |
|---|
| 92. |
Seki R, Ohshima K, Nagafuji K, Fujisaki T, Uike N, Kawano F, Gondo H, Makino S, Eto T, Moriuchi Y, Taguchi F, Kamimura T, Tsuda H, Ogawa R, Shimoda K, Yamashita K, Suzuki K, Suzushima H, Tsukazaki K, Higuchi M, Utsunomiya A, Iwahashi M, Imamura Y, Tamura K, Suzumiya J, Yoshida M, Abe Y, Matsumoto T, Okamura T. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group. Int J Hematol. 2010; 91(2): 257-266. |
|---|
| 93. |
Seki R, Ohshima K, Fujisaki T, Uike N, Kawano F, Gondo H, Makino S, Eto T, Moriuchi Y, Taguchi F, Kamimura T, Tsuda H, Shimoda K, Okamura T. Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab. Ann Oncol. 2010; 21: 833-841. |
|---|
| 94. |
Ushijima K. Treatment for recurrent ovarian cancer - at first relapse. Journal of Oncolog. 2010; 1-7. |
|---|
| 95. |
Satoh T，Hatae M，Watanabe Y，Yaegashi N，Ishiko Osamu，Kodama S，Yamaguchi S，Ochiai K，Takano M，Yokota H，Kawakami Y，Nishimura S，Ogishima D，Nakagawa S，Kobayashi H，Shiozawa T，Nakanishi T，Kamura T，Konishi I ，Yoshikawa H. Outcomes of fertility-sparding surgery for stage I epithelial ovarian cancer : a proposal for patient selection. J Cln oncol. 2010; 28: 1727-1732. |
|---|
| 96. |
Kamura T. Overview on the 1st International Workshop on Gynecologic Oncology. J Gynecol Oncol. 2010; 21: 135-136. |
|---|
| 97. |
Nonoshita A，Nishi Y，Takushima S，Oshima M，Hosoda H，Kangawa K，Kojima M，Mifune H，Tanaka E，Hori D，Kamura T. Dynamics of placental ghrelin production and its receptor expression in a Dahl salt-sensitive rat model of intrauterine growth restriction. Placenta. 2010; 31: 358-364. |
|---|
| 98. |
Ando N, Sato K, Mitsukawa M, Yamada K, Wakioka T, Nagata K. Surgical results of percutaneous suction aspiration and drainage for pyogenic spondylitis. Kurume Med J. 2010; 57(3): 43-9. |
|---|
| 99. |
Keishiro Aoyagi, Kikuo Kouhuji, Motoshi Miyagi, Takuya Imaizumi, Junya Kizaki, Kazuo Shirouzu. Prognosis of metastatic splenic hilum lymph node in patients with gastric cancer after total gastrectomy and splenectomy. World Journal of Hepatology. 2010; 2(2): 81-86. |
|---|
| 100. |
Hirotoshi Kobayashi, Hidetaka Mochizuki, Tomoyuki Kato, Takeo Mori, Shingo Kameoka, Kazuo Shirouzu, Yukio Saito, Masahiko Watanabe, Takayuki Morita, Jin-ichi Hida, Masashi Ueno, Masato Ono, Masamichi Yasuno, Kenichi Sugihara. Is Total Mesorectal Excision Always Necessary for T1-T2 Lower Rectal Cancer? Ann surg Oncol. 2010; 17: 973-980. |
|---|
| 101. |
Yoshito Akagi, Takanaru Fukushima, Tomoaki Mizobe, Ichitaro Shiratsuchi, Yasuhiko Ryu, Takefumi Yoshida, Nobuya Ishibashi, Tetsushi Kinugasa, Kazuo Shirouzu. Challenges in Staging Systems for Colorectal Cancer: Clinical Singnicance of Metastatic Lymph Node Number in Colorectal Cancer and Mesorectal Extension in Rectal Cancer. Digestion. 2010; 82: 192-197. |
|---|
| 102. |
Takuya Imaizumi, Keishiro Aoyagi, Motoshi Miyagi, Kazuo Shirouzu. Suppressive Effect of Bevacizumab on Peritoneal Dissemination from Gastic Cancer in a Peritoneal Metastasis Model. Surgery Today. 2010; 40: 851-857. |
|---|
| 103. |
T.Tanaka, S.Matono, T.nagano, K.Nishimura, K.Murata, H.Yamana, K.Shirouzu, H.Fujita. Surgical management for small cell carcinoma of the esophagus. Diseases of the Esophagus. 2010; 23: 502-505. |
|---|
| 104. |
Tetsushi Kinugasa, Yoshito Akagi, Takefumi Yoshida, Yasuhiko Ryu, Ichitarou Shiratutchi, Nobuya Ishibashi, Kazuo Shirouzu. Increased Claudin-1 Protein Expression Contributes to Tumorigensis in Ulcerative Colitis-associated Colorectal Cancer. Anticancer Research. 2010; 30: 3181-3186. |
|---|
| 105. |
T.Tanaka, H.Fujita, S.Matono, T,Nagano, K.Nishimura, K.Shirouzu, G.Suzuki, N.Hayabuchi, H.Yamana. Outcomes of multimodality therapy for stage IVB esophageal cancer with distant organ metastasis (M1-Org). Diseases of the Esophagus. 2010; 23: 646-651. |
|---|
| 106. |
Masanori Noguchi, Takashi Mone, Nobukazu Komatsu, Shigetaka Suekane, Fukuko Moriya, Kei Matsuoka, Shigeru Yutani, Shigeki Shichijo, Akira Yamada, Uhi Toh, Kouidhiro Kawano, Kouichi Azuma, Hirotsugu Uemura, Kiyotaka Okino, Kazumasa Matsumoto, Hiroaki Yamanaka, Masaaki Oka, Satoru Todo, Tatsuro Sasada, Kyogo Itoh. Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination. Cancer Biology & Therapy. 2010; 10(12): 1266-1279. |
|---|
| 107. |
Naoko Seki, Uhi Toh, Thomas J. Sayers,Teruhiko Fujii, Motoshi Miyagi, Yoshito Akagi, Jingo Kusukawa, Masayoshi Kage, Kazuo Shirouzu, Hideaki Yamana. Bortezomib Sensitizes Human Esophageal Squamous Cell Carcinoma Cells to TRAIL-Mediated Apoptosis via Activation of Both Extrinsic and Intrinsic Apoptosis Pathways Molecular Cancer Therapeutics. 2010; 9(6): 1842-1851. |
|---|
| 108. |
Kurata S, Ishibashi M, Azuma K, Kaida H, Takamori S, Fujimoto K, Kobayashi M, Hirose Y, Aizawa H, Hayabuchi N. Preliminary study of positron emission tomography/computed tomography and plasma osteopontin levels in patients with asbestos-related pleural disease. Jpn J Radiol. 2010; 28(6): 446-452. |
|---|
| 109. |
Miura S, Azuma K, Yamada K, Takamori S, Kawahara A, Noda K, Ayabe M, Kage M, Aizawa H, Taniwaki T. Combined treatment with prednisolone and tacrolimus for myasthenia gravis with invasive thymoma. Acta Neurol Belg. 2010; 110(1): 107-109. |
|---|
| 110. |
Nishi T, Takamori S, Muta F, Yoshiyama K, Iwasaki Y, Shirouzu K. Nonmalignant pericardial effusion associated with thymic cancer. Gen Thorac Cardiovasc Surg. 2010; 58(5): 239-242. |
|---|
| 111. |
Sasada S, Namoto-Matsubayashi R, Yokoyama G, Takahashi H, Sakai M, Koike K, Momosaki S, Uesugi N, Fujii T. Case report of pseudoaneurysm caused by core needle biopsy of the breast. Breast Cancer. 2010; 17: 75-78. |
|---|
| 112. |
Namoto Matsubayashi R, Fujii T, Yasumori K, Muranaka T. Apparent diffusion coefficient in invasive breast carcinoma: Correlation with the enhancement ratio on dynamic contrast-enhanced MR Images and detailed histologic features. J. Oncol. 2010; 2010. pii: 821048. Epub. 2010 Sep 2. |
|---|
| 113. |
Ishikawa M, Takamatsu Y, Mitsuyama S, Iwakuma N, Anan K, Umeda S, Tamura K. “Paclitaxel as a first-line chemotherapy for Japanese women with advanced or recurrent breast cancer: multi-institutional practice-based study by Kyushu Breast Cancer Group (KBC-SG).” Breast Cancer. 2010, Vol. 17(2), 131-135. |
|---|
| 114. |
Karino Y, Toyota J, Kumada H, Katano Y, Izumi N, Kobashi H, Sata M, Moriyama M, Imazeki F, Kage M, Ishikawa H, Masaki N, Seriu T, Omata M.Erratum to: Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B. Hepatol Int. 2010: 30; 4(4): 789-90. |
|---|
| 115. |
Yamamoto C, Basaki Y, Kawahara A, Nakashima K, Kage M, Izumi H, Kohno K, Uramoto H, Yasumoto K, Kuwano M, Ono M. Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations. Cancer Res. 2010; 70(21): 8715-25. |
|---|
| 116. |
Kawahara A, Hattori S, Akiba J, Nakashima K, Taira T, Watari K, Hosoi F, Uba M, Basaki Y, Koufuji K, Shirouzu K, Akiyama S, Kuwano M, Kage M, Ono M. Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer. Oncol Rep. 2010; 24 (2): 405-15. |
|---|
| 117. |
Kaida H, Ishibashi M, Yuzuriha M, Kurata S, Arikawa S, Kawahara A, Uozumi J, Uchida M, Kobayashi M, Hirose Y, Fujita H, Kage M, Hayabuchi N. Glucose transporter expression of an esophageal gastrointestinal tumor detected by F-18 FDG PET/CT. Clin Nucl Med. 2010; 35(7): 505-9. |
|---|
| 118. |
Morinaga A, Ogata T, Kage M, Kinoshita H, Aoyagi S. Comparison of liver regeneration after a splenectomy and splenic artery ligation in a dimethylnitrosamine-induced cirrhotic rat model. HPB (Oxford). 2010; 12(1): 22-30. |
|---|
| 119. |
Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Kaneko Y, Yamaguchi M, Ogata Y, Nakashima O, Kage M, Yano H. Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis. Jpn J Clin Oncol. 2010; 40(8): 781-7. |
|---|
| 120. |
Nakanuma Y, Zen Y, Harada K, Sasaki M, Nonomura A, Uehara T, Sano K, Kondo F, Fukusato T, Tsuneyama K, Ito M, Wakasa K, Nomoto M, Minato H, Haga H, Kage M, Yano H, Haratake J, Aishima S, Masuda T, Aoyama H, Miyakawa-Hayashino A, Matsumoto T, Sanefuji H, Ojima H, Chen TC, Yu E, Kim JH, Park YN, Tsui W. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int. 2010; 60(3): 167-74. |
|---|
| 121. |
Yamaguchi R, Tanaka M, Yamaguchi M, Fukushima T, Kaneko Y, Otsuka H, Isobe S, Terasaki H, Nakashima O, Kage M, Yano H. Pleomorphic carcinoma of the breast in a 17-year-old woman. Med Mol Morphol. 2010; 43(1): 43-7. |
|---|
| 122. |
Karino Y, Toyota J, Kumada H, Katano Y, Izumi N, Kobashi H, Sata M, Moriyama M, Imazeki F, Kage M, Ishikawa H, Masaki N, Seriu T, Omata M. Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B. Hepatol Int. 2010; 4(1): 414-22. |
|---|
| 123. |
Shiota M, Saitou K, Mizumoto H, Matsusaka M, Agata N, Nakayama M, Kage M, Tatsumi S, Okamoto A, Yamaguchi S, Ohta M, Hata D. Rapid detoxification of cereulide in Bacillus cereus food poisoning. Pediatrics. 2010; 125(4): e951-5. |
|---|
| 124. |
Kobayashi H, Tanaka Y, Asagiri K, Asakawa T, Tanikawa K, Kage M, Yagi M. The antioxidant effect of green tea catechin ameliorates experimental liver injury. Phytomedicine. 2010; 17(3-4): 197-202. |
|---|
| 125. |
Tajiri T, Yoshida H, Obara K, Onji M, Kage M, Kitano S, Kokudo N, Kokubu S, Sakaida I, Sata M, Tajiri H, Tsukada K, Nonami T, Hashizume M, Hirota S, Murashima N, Moriyasu F, Saigenji K, Makuuchi H, Oho K, Yoshida T, Suzuki H, Hasumi A, Okita K, Futagawa S, Idezuki Y. General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc. 2010; 22(1): 1-9. |
|---|
| 126. |
Kimura A, Kage M, Nagata I, Mushiake S, Ohura T, Tazawa Y, Maisawa S, Tomomasa T, Abukawa D, Okano Y, Sumazaki R, Takayanagi M, Tamamori A, Yorifuji T, Yamato Y, Maeda K, Matsushita M, Matsuishi T, Tanikawa K, Kobayashi K, Saheki T. Histological findings in the livers of patients with neonatal intrahepatic cholestasis caused by citrin deficiency. Hepatol Res. 2010; 40(4): 295-303. |
|---|
| 127. |
Yamaguchi R, Tanaka M, Yokoyama T, Nonaka Y, Kojima K, Terasaki H, Yamaguchi M, Fukunaga M, Toh U, Nakashima O, Kage M, Yano H. Clinicocytopathology of breast cancers with a ring-like appearance on ultrasonography and/or magnetic resonance imaging. Pathol Int. 2010 Jan;60(1):22-6. Erratum in: Pathol Int. 2010; 60(4): 336. |
|---|
| 128. |
Kawahara A, Harada H, Mihashi H, Akiba J, Kage M. Cytological features of cystadenocarcinoma in cyst fluid of the parotid gland: Diagnostic pitfalls and literature review. Diagn Cytopathol. 2010; 38(5): 377-81. |
|---|
| 129. |
Tajiri T, Yoshida H, Obara K, Onji M, Kage M, Kitano S, Kokudo N, Kokubu S, Sakaida I, Sata M, Tajiri H, Tsukada K, Nonami T, Hashizume M, Hirota S, Murashima N, Moriyasu F, Saigenji K, Makuuchi H, Oho K, Yoshida T, Suzuki H, Hasumi A, Okita K, Futagawa S, Idezuki Y. General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc. 2010 Jan; 22 (1): 1-9. |
|---|
| 130. |
Morinaga A, Ogata T, Kage M, Kinoshita H, Aoyagi S. Comparison of liver regeneration after a splenectomy and splenic artery ligation in a dimethylnitrosamine-induced cirrhotic rat model. HPB(Oxford, England). 2010 Feb; 12 (1): 22-30. |
|---|
| 131. |
Miura S, Azuma K, Yamada K, Takamori S, Kawahara A, Noda K, Ayabe M, Kage M, Aizawa H, Tanikawa T. Combined treatment with prednisolone and tacrikunys fir myasthenia gravis with invasive thymoma. Acta neurologica Belgica. 2010 Mar; 110 (1): 107-109. |
|---|
| 132. |
Kaida H, Ishibashi M, Yuzuriha M, Kurata S, Arikawa S, Kawahara A, Uozumi J, Uchida M, Kobayashi M, Hirose Y, FUjita H, Kage M, Hayabuchi N. Glucose transporter expression of an esophageal gastrointestinal tumor detected by F-18 FDG PET/CT. Clinical nuclear medicine. 2010 Jul; 35 (7): 505-509. |
|---|
| 133. |
Kawahaara A, Hattori S, Akiba J, Nakashima K, Taira T, Watari K, Hosoi F, Uba M, Basaki Y, Koufuji K, Shirouzu K, Akiyama S, Kuwano M, Kage M, Ono M. Infilitration of thymidine phosphorylase- positive macrophages is closely associated wit tumor angiogenesis and survival in intensinal type gastric cancer. Oncology reports. 2010 Aug; 24 (2):405-415. |
|---|
| 134. |
Shoujiro Torigoe, Yutaka Ogata, Keiko Matono, Kazuo Shirouzu. Molecular Mechanisms of Sequence-dependent Antitumor Effects of SN-38 and 5-Fluorouracil Combination Therapy against Colon Cancer Cells. ANTICANCER RESEARCH . 2009; 29: 2083-2090. |
|---|
| 135. |
Satoru Matono, Hiromasa Fujii, Toshiaki Tanaka, Yuichi Tanaka, Susumu Sueyoshi, Tatsuji Tsubuku, Kohei Nishimura, Kazutaka Murata, Kazuo Shirouzu. Malignant acanthosis nigricans with esophageal cancer Esophagus. 2009; 6; 127-131. |
|---|
| 136. |
Kazuo Shirouzu, Yutaka Ogata Histopathologic Tumor Spread in Very Low Rectal Cancer Treated with Abdminoperineal Resection DISEASES OF COLON & RECTUM. 2009; 52(11); 1887-1894. |
|---|
| 137. |
Yutaka Ogata, Teruo Sasatomi, Yoshito Akagi, Nobuya Ishibashi, Shinjirou mori, Kazuo Shirouzu . Dosage Escalation Study of S-1 and Irinotecan in Metronomic Chemotherapy against Advanced Colorectal Cancer Kurume Medical Journal. 2009; 56(1,2); 1-7. |
|---|
| 138. |
Keishiro Aoyagi, Kikuo Kouhuji, Shojiro Yano, Motoshi Miyagi, Takuya Imaizumi, Jinryo Takeda, Kazuo Shirouzu. Malignant Potential of Gastrointestinal Stromal Tumor of the Stomach INTERNATIONAL SURGERY. 2009; 94; 1-9. |
|---|
| 139. |
Yuichiro Maruyama, Hiroyuki Horiuchi, Yoshinobu Okabe, Ryuichi Kawahara, Shinji Uchida, Takenori Sakai, Hiroto Ishikawa, Kazuhiro Mikagi, Munehiro Yoshitomi, Yusuke Kawashima, Manami Fujishima, Gen Akasu, Mitsuru Katsumoto, Daimei Eto, Mitsutoshi Ureshino, Yuichi Goto, Hiroki Ureshino, and Hisafumi Kinoshita. Perioperative challenges associated with a pancreaticoduodenectomy and distal pancreatectomy for pancreatic cancer in patients with situs inversus totalis: report of two cases. Surgery Today. 2010; 40(1): 79-82. |
|---|
| 140. |
Sasada S, Namoto-Matsubayashi R, Yokoyama G, Takahashi H, Sakai M,Koike K, Momosaki S, Uesugi N, Fujii T. Case Report of Pseudoaneurysm caused by Core Needle Biopsy of the Breast. Breast Cancer. 2010; 17(1): 75-8. |
|---|
| 141. |
Nagamitsu S, Yamashita F, Araki Y, Iizuka C, Ozono S, Komatsu H, Ohya T, Yamashita Y, Kakuma T, Tsuda A, Matsuishi T. Characteristic prefrontal blood volume patterns when imaging body type, high-calorie food, and mother-child attachment in childhood anorexia nervosa: A near infrared spectroscopy study. Brain Dev. 2010; 32(2): 162-7. |
|---|
| 142. |
Kawahara, A., Yamamoto, C., Nakashima, K., Azuma, K., Hattori, A., Kashihara, M., Aizawa, H., Basaki, Y., Kuwano, M., and Ono, M. Molecular diagnosis of activationg EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysis. Clinic. Cancer Res. 2010; 16: 3163-3170. |
|---|
| 143. |
Murakami, Y., Hosoi, F., Izumi, H., Maruyama, Y., Ureshino, H., Watari, K., Kohno, K., Kuwano, M., and Ono, M. Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells. Biochemical and Biophysical Research Communications. 2010; 396: 376-381. |
|---|
| 144. |
Imamura Y, Azuma K, Kurata S, Hattori S, Sasada T, Kinoshita T, Okamoto M, Kawayama T, Kaida H, Ishibashi M, Aizawa H. Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy. Lung Cancer. 2010 Apr 27(in press). |
|---|
| 145. |
Seki N, Toh U, Sayers TJ, Fujii T, Miyagi M, Akagi Y, Kusukawa J, Kage M, Shirouzu K, Yamana H. Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways. Mol Cancer Ther 2010; 9: 1842-51. |
|---|
| 146. |
Yamada K, Yamamoto N, Yamada Y, Mukohara T, Minami H, Tamura T. Phase I and pharmacokinetic study of ABI-007, albumin-bound paclitaxel, administered every 3 weeks in Japanese patients with solid tumors. Jpn J Clin Oncol. 2010; 40: 404-411. |
|---|
| 147. |
Fujisaka Y, Yamada Y, Yamamoto N, Shimizu T, Fujiwara Y, Yamada K, Tamura T, Watanabe H, Sun YN, Bass MB, Seki M. Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors. Cancer Chemother Pharmacol.(in press.) |
|---|
| 148. |
Yamada K, Nakao M, Fukuyama C, Nokihara H, Yamamoto N, Sekine I, Kunitoh H, Ohe Y, Ohki E, Hashimoto J, Tamura T. Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer. Cancer Sci. 2010; 101: 188-195. |
|---|
| 149. |
Nonoshita A，Nishi Y，Takushima S，Oshima M，Hosoda H，Kangawa K，Kojima M，Mifune H，Tanaka E，Hori D，Kamura T. Dynamics of placental ghrelin production and its receptor expression in a Dahl salt-sensitive rat model of intrauterine growth restriction. Placenta. 2010; 31: 358-364. |
|---|
| 150. |
Seki R, Ohshima K, Fujisaki T, Uike N, Kawano F, Gondo H, Makino S, Eto T, Moriuchi Y, Taguchi F, Kamimura T, Tsuda H, Shimoda K, Okamura T Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab. Ann Oncol. 2010; 21: 833-841. |
|---|
| 151. |
Seki R, Ohshima T, Nagafuji K, et al. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B-cell lymphoma in Japan: A retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group. Int J Hematol. 2010; 91: 258-266. |
|---|
| 152. |
Yagi M, Sato N, Mitsui Y, Gotoh M, Hamada T, Nagata K. J Hand Surg Am. Hyaluronan modulates proliferation and migration of rabbit fibroblasts derived from flexor tendon epitenon and endotenon. 2010; May; 35(5): 791-6. |
|---|
| 153. |
Nago M, Mitsui Y, Gotoh M, Nakama K, Shirachi I, Higuchi F, Nagata K. Hyaluronan modulates cell proliferation and mRNA expression of adhesion-related procollagens and cytokines in glenohumeral synovial/capsular fibroblasts in adhesive capsulitis. J Orthop Res. 2010; Jun; 28(6): 726-31. |
|---|
| 154. |
Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Kaneko Y, Yamaguchi M, Ogata Y, Nakashima O, Kage M, Yano H. Characteristic Morphology of Invasive Micropapillary Carcinoma of the Breast: An Immunohistochemical Analysis. Jpn J Clin Oncol. 2010 Aug; 40(8): 781-7. |
|---|
| 155. |
Yamaguchi R, Tanaka M, Yamaguchi M, Fukushima T, Kaneko Y, Otsuka H, Isobe S, Terasaki H, Nakashima O, Kage M, Yano H. Pleomorphic carcinoma of the breast in a 17-year-old woman. Med Mol Morphol. 2010; Mar; 43(1): 43-7. |
|---|
| 156. |
Tanaka M, Takamatsu Y, Anan K, Ohno S, Nishimura R, Yamamoto Y, Masuda N, Mitsuyama S, Tamura K. Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study. Kyushu Breast Cancer Study Group. Anticancer Drugs. 2010 Apr; 21(4): 453-8. |
|---|
| 157. |
Yamaguchi R, Tanaka M, Yokoyama T, Nonaka Y, Kojima K, Terasaki H, Yamaguchi M, Fukunaga M, Toh U, Nakashima O, Kage M, Yano H. Clinicocytopathology of breast cancers with a ring-like appearance on ultrasonography and/or magnetic resonance imaging. Pathol Int. 2010; Jan; 60(1): 22-6. |
|---|
| 158. |
Inoue H, Hiraoka K, Hoshino T, Okamoto M, Iwanaga T, Zenmyo M, Shoda T, Aizawa H, Nagata K. High levels of serum IL-18 promote cartilage loss through suppression of aggrecan synthesis. Bone. 2008 Jun; 42(6): 1102-10. |
|---|
| 159. |
Shimoyama T, Hiraoka K, Shoda T, Hamada T, Fukushima N, Nagata K. Multicentric extra-abdominal desmoid tumors, arising from bilateral lower limbs. Rare tumors. 2010; 2:e12. |
|---|
| 160. |
Matsugaki T, Zenmyo M, Hiraoka K, Fukushima N, Shoda T, Komiya S, Ono M, Kuwano M, Nagata K: N-myc downstream-regulated gene 1/Cap43 expression promotes cell differentiation of human osteosarcoma cells. Oncology Reports. 2010; 24: 721-5. |
|---|
| 161. |
Sato H, Oka T, Shinnou Y, Kondo T, Washio K, Takano M, Takata K, Morito T, Huang X, Tamura M, Kitamura Y, Ohara N, Ouchida M, Ohshima K, Shimizu K, Tanimoto M, Takahashi K, Matsuoka M, Utsunomiya A, Yoshino T. Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma. Am J Pathol. 2010; 176(1): 402-15. |
|---|
| 162. |
Sasada S, Namoto-Matsubayashi R, Yokoyama G, Takahashi H, Sakai M, Koike K, Momosaki S, Uesugi N, Fujii T. Case report of pseudoaneurysm caused by core needle biopsy of the breast. Breast Cancer. 2010; 17: 75-78. |
|---|
| 163. |
Seki N, Toh U, Sayers TJ, Fujii T, Miyagi M, Akagi Y, Kusukawa J, Kage M, Shirouzu K, Yamana H. Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways. Mol Cancer Ther. 2010. 9: 1842-1851. |
|---|
| 164. |
Sato I, Higuchi A, Yanagisawa T, Mukasa A, Ida K, Sawamura Y, Sugiyama K, Saito N, Kumabe T, Terasaki M, Nishikawa R, Ishida Y, Kamibeppu K. Development of the Japanese version of the Pediatric Quality of Life Inventory Brain Tumor Module. Health Qual Life Outcomes. 2010 Apr; 14: 8: 38. |
|---|
| 165. |
Keishiro Aoyagi, Kikuo Kouhuji, Motoshi Miyagi, Takuya imaizumi, Junya Kizaki, Kazuo Shirouzu . Prognosis of metastatic splenic hilum lymph node in patients with gastric cancer after total gastrectomy and splenectomy. World Journal of Hepatology. 2010; 2(2): 81-86. |
|---|
| 166. |
Hirotoshi Kobayashi, Hidetaka Mochizuki, tomoyuki Kato, Takeo Mori, Shingo Kameoka, Kazuo Shirouzu, Yukio Saito, Masahiko Watanabe, Takayuki Morita, Jin-ichi Hida, Masashi Ueno, Masato Ono, Masamichi Yasuno, Kenichi Sugihara. Is Total Mesorectal Excision Always Necessary for T1-T2 Lower Rectal Cancer? Ann surg Oncol. 2010; 17: 973-980. |
|---|
| 167. |
Yoshito Akagi, Takanaru Fukushima, Tomoaki Mizobe, Ichitaro Shiratsuchi, Yasuhiko Ryu, Takefumi Yoshida, Nobuya Ishibashi, Tetsushi Kinugasa, Kazuo Shirouzu. Challenges in Staging Systems for Colorectal Cancer: Clinical Singnicance of Metastatic Lymph Node Number in Colorectal Cancer and Mesorectal Extension in Rectal Cancer. Digestion. 2010; 82: 192-197. |
|---|
| 168. |
Sugita Y, Terasaki M, Niino D, Ohshima K, Fumiko A, Shigemori M, Sato Y, Asano N. Epstein-Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing. J Neurooncol. 2010 May 9. (in press.). |
|---|
| 169. |
Terasaki M, Eto T, Nakashima S, Okada Y, Ogo E, Sugita Y, Tokutomi T, Shigemori M. A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme. J Neurooncol. 2010 Jul 17. (in press.). |
|---|
| 170. |
Fujii T, Nakamura AM, Takahashi H, Namoto Matsubayashi R, Inoue Y, Takenaka M, Iwakuma N, Otsuka H, Toh U, Yamana H, Kage M, Shirouzu K. Cell-cycle regulation by protein kinase C and mitogen-activated protein kinase signaling in breast cancer cells. Current Topics in Biochemical Research 2010. (in press.). |
|---|
| 171. |
Namoto Matsubayashi R, Fujii T, Yasumori K, Muranaka T. Apparent diffusion coefficient in invasive breast carcinoma: Correlation with the enhancement ratio on dynamic contrast-enhanced MR Images and detailed histologic features. Journal of Oncology 2010. (in press.) |
|---|
| 172. |
Hosoi F, Izumi H, Kawahara A, Murakami Y, Kinoshita H, Kage M, Nishio K, Kohno K, Kuwano M, Ono M. N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression. Cancer Res. 2009 Jun 15; 69(12): 4983-91. |
|---|
| 173. |
Fujii T, Seki N, Namoto-Matsubayashi R, Takahashi H, Inoue Y, Toh U, Kage M, Shirouzu K. YB-1 prevents apoptosis via the mTOR/STAT3 pathway in HER-2-overexpressing breast cancer cells. Future Oncol. 2009 Mar; 5(2): 153-6. |
|---|
| 174. |
Fujii T, Takahashi H, Namoto Matsubayashi R, Inoue Y, Takenaka M, Toh U, Kage M, Yamana H, Shirouzu K. First-line treatment of metastatic breast cancer: focus on bevacizumab. Clin Med. 2009; 1: 583-593. |
|---|
| 175. |
Kobashi H, Takaguchi K, Ikeda H, Yokosuka O, Moriyama M, Imazeki F, Kage M, Seriu T, Omata M, Sakaguchi K, Shiratori Y. Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: phase II clinical study in Japan. J Gastroenterol Hepatol. 2009 Feb; 24(2): 255-61. |
|---|
| 176. |
Kawahara A, Akagi Y, Hattori S, Mizobe T, Shirouzu K, Ono M, Yanagawa T, Kuwano M, Kage M. Higher expression of deoxyuridine triphosphatase (dUTPase) may predict the metastasis potential of colorectal cancer. J Clin Pathol. 2009 Apr; 62(4): 364-9. |
|---|
| 177. |
Azuma K, Sasada T, Kawahara A, Takamori S, Hattori S, Ikeda J, Itoh K, Yamada A, Kage M, Kuwano M, Aizawa H. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel. Lung Cancer. 2009 Jun; 64(3): 326-33. |
|---|
| 178. |
Nakagawa M, Nakagawa-Oshiro A, Karnan S, Tagawa H, Utsunomiya A, Nakamura S, Takeuchi I, Ohshima K, Seto M. Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia/lymphoma. Clin Cancer Res. 2009; 15(1): 30-8. |
|---|
| 179. |
Suzumiya J, Ohshima K, Tamura K, Karube K, Uike N, Tobinai K, Gascoyne RD, Vose JM, Armitage JO, Weisenburger DD; for the International Peripheral T-cell Lymphoma Project. The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project. Ann Oncol. 2009; 20(4): 715-21. |
|---|
| 180. |
Okamatsu Y, Matsuda K, Hiramoto I, Tani H, Kimura K, Yada Y, Kakuma T, Higuchi S, Kojima M, Matsuishi T. Ghrelin and leptin modulate immunity and liver function in overweight children. Pediatr Int. 2009; 51(1): 9-13. |
|---|
| 181. |
Ogata Y, Murakami H, Sasatomi T, Ishibashi N, Mori S, Ushijima M, Akagi Y, Shirouzu K. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer. J Surg Oncol. 2009 Jan 1; 99(1): 65-70. |
|---|
| 182. |
Huo Q, Kinugasa T, Wang L, Huang J, Zhao J, Shibaguchi H, Kuroki M, Tanaka T, Yamashita Y, Nabeshima K, Iwasaki H, Kuroki M. Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res. 2009 Mar; 29(3): 851-7. |
|---|
| 183. |
Matono S, Fujita H, Tanaka T, Tanaka Y, Tsubuku T, Nishimura K, Murata K, Shirouzu K. Giant gastrointestinal stromal tumor in the esophagus. Esophagus. 2009 Mar; 6(1): 49-54. |
|---|
| 184. |
Sato K, Umeno H, Chitose S, Nakashima T. Tetra-probe, 24-hour pH monitoring for laryngopharyngeal reflux: a technique for simultaneous study of hypopharynx, oesophagus and stomach. J Laryngol Otol. 2009 May; 123 Suppl 31: 117-22 |
|---|
| 185. |
Chitose S, Umeno H, Hamakawa S, Gondou K, Nakashima T. Cricopharyngeal dysfunction with significant piriform sinus expansion: case report. J Laryngol Otol. 2009 May; 123 Suppl 31: 108-12. |
|---|
| 186. |
Chijiwa H, Mihashi H, Sakamoto K, Umeno H, Nakashima T. Supraglottic carcinoma treatment results analysed by therapeutic approach. J Laryngol Otol. 2009 May; 123 Suppl 31: 104-7. |
|---|
| 187. |
Chijiwa H, Mihoki T, Shin B, Sakamoto K, Umeno H, Nakashima T. Clinical study of parapharyngeal space tumours. J Laryngol Otol. 2009 May; 123 Suppl 31: 100-3. |
|---|
| 188. |
Umeno H, Chitose S, Ueda Y, Kurita T, Mihashi H, Nakashima T. New silicone tube placement therapy for patients with an anterior glottic web. J Laryngol Otol. 2009 May; 123 Suppl 31: 97-9. |
|---|
| 189. |
Ueda Y, Kurita T, Matsuda Y, Ito S, Nakashima T. Superselective, intra-arterial, rapid infusion chemotherapy for external auditory canal carcinoma. J Laryngol Otol. 2009 May; 123 Suppl 31: 75-80. |
|---|
| 190. |
Sato K, Umeno H, Nakashima T. Conservative treatment for recurrent dislocation of temporomandibular joint. J Laryngol Otol. 2009 May; 123 Suppl 31: 72-4. |
|---|
| 191. |
Chitose S, Umeno H, Nakashima T. Endoscopic surgical treatment of posterior glottic stenosis. J Laryngol Otol. 2009 May; 123 Suppl 31: 68-71. |
|---|
| 192. |
Ueda Y, Kurita T, Matsuda Y, Ito S, Nakashima T. Surgical treatment of labyrinthine fistula in patients with cholesteatoma. J Laryngol Otol. 2009 May; 123 Suppl 31: 64-7. |
|---|
| 193. |
Sakamoto K, Ono T, Nakamura Y, Harada H, Nakashima T. Expression of cluster of differentiation 9 glycoprotein in benign and malignant parotid gland tumours. J Laryngol Otol. 2009 May; 123 Suppl 31: 58-63. |
|---|
| 194. |
Chijiwa H, Sakamoto K, Umeno H, Nakashima T, Suzuki G, Hayafuchi N. Minor salivary gland carcinomas of oral cavity and oropharynx. J Laryngol Otol. 2009 May; 123 Suppl 31: 52-7. |
|---|
| 195. |
Sato K, Umeno H, Chitose S, Nakashima T. Patterns of laryngopharyngeal and gastroesophageal reflux. J Laryngol Otol. 2009 May; 123 Suppl 31: 42-7. |
|---|
| 196. |
Umeno H, Chitose S, Sato K, Nakashima T. Comparative study of framework surgery and fat injection laryngoplasty. J Laryngol Otol. 2009 May; 123 Suppl. 31: 35-41. |
|---|
| 197. |
Nakashima T, Mihoki T, Ono T, Umeno H, Tanaka N. Selective (intra-arterial), rapid infusion chemo-radiotherapy to preserve the larynx in advanced laryngeal carcinoma: preliminary results. J Laryngol Otol. 2009 May; 123 Suppl. 31: 30-4. |
|---|
| 198. |
Dong P, Li X, Wang G, Chen X, Xie J, Nakashima T. Repair with sternohyoid muscle fascia after subtotal laryngectomy. J Laryngol Otol. 2009 May; 123 Suppl 31: 18-23. |
|---|
| 199. |
Li X, Sakamoto K, Takahashi Y, Nakashima T. Overexpression of Cap43 gene in supraglottic laryngeal squamous cell carcinoma. J Laryngol Otol. 2009 May; 123 Suppl 31: 11-7. |
|---|
| 200. |
Li X, Takahashi Y, Sakamoto K, Nakashima T. Expression of dendritic cell phenotypic antigens in cervical lymph nodes of patients with hypopharyngeal and laryngeal carcinoma. J Laryngol Otol. 2009 May; 123 Suppl 31: 5-10. |
|---|
| 201. |
Sato K, Nakashima T. Sleep-related deglutition in patients with sleep apnea-hypopnea syndrome. Ann Otol Rhinol Laryngol. 2009 Jan; 118(1): 30-6. |
|---|
| 202. |
Sato K, Nakashima T. Stellate cells in the human child vocal fold macula flava. Laryngoscope. 2009 Jan; 119(1): 203-10. |
|---|
| 203. |
Kashihara, M., Azuma, K., Kawahara, A., Basaki, Y., Hattori, S., Yanagawa, T., Terazaki, Y., Takamori, S., Shirouzu, K., Aizawa, H., Nakao, K., Kage, M., Kuwano, M., Ono, M. Nuclear Y-box binding protein-1 (YB-1) a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer. J Thorac Oncol. 2009 ; 4(9): 1066-74. |
|---|
| 204. |
Azuma K, Sasada T, Kawahara A, Takamori S, Hattori S, Ikeda J, Itoh K, Yamada A, Kage M, Kuwano M, Aizawa H. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel. Lung Cancer. 2009 Jun; 64(3): 326-33. |
|---|
| 205. |
Yamamoto N, Yamada Y, Fujiwara Y, Yamada K, Fujisaka Y, Shimizu T, Tamura T. Phase I and pharmacokinetic study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese patients with solid tumors. Jpn J Clin Oncol 2009; 39: 260-266. |
|---|
| 206. |
Yamamoto N, Tamura T, Yamamoto N, Yamada K, Yamada Y, Nokihara H, Fujiwara Y, Takahashi T, Murakami H, Boku N, Yamazaki K, Puchalski TA, Shin E. Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors. Cancer Chemother Pharmacol 2009; 64: 1165-1172. |
|---|
| 207. |
Kawaishi M, Fujiwara Y, Fukui T, Kato T, Yamada K, Ohe Y, Kunitoh H, Sekine I, Yamamoto N, Nokihara H, Watabe T, Shimoda Y, Arao T, Nishio K, Tamura T, Koizumi F. Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel. J Thorac Oncol .2009; 4: 208-213. |
|---|
| 208. |
Goto Y, Sekine I, Sekiguchi H, Yamada K, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T.Differences in the quality of information on the internet about lung cancer between the United States and Japan. J Thorac Oncol. 2009; 4: 829-833. |
|---|
| 209. |
Fujiwara Y, Yamamoto N, Yamada Y, Yamada K, Otsuki T, Kanazu S, Iwasa T, Hardwick JS, Tamura T.Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors. Cancer Sci. 2009; 100: 1728-1734. |
|---|
| 210. |
Onda T，Kobayashi H，Nakanishi T，Hatae M，Iwasaka T，Konishi I ，Shibata T，Fukuda H，Kamura T，Yoshikawa H. Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers : Japan Clinical Oncology Group Study JCOG 0206. Gynecol Oncol. 2009; 113: 57-65. |
|---|
| 211. |
Nishio S，Katsumata N，Matsumoto K，Tanabe H，Yonemori K，Kouno T，Shimizu C，Ando M，Kamura T，Kasamatsu T，Fujiwara Y. Usefulness of third-line chemotherapy for women with recurrent ovarian , fallopian tube, and primary peritoneal cancer who receive platinum / taxane regimens as first - line therapy. J Cancer Res Clin Oncol. 2009; 135: 551- 557. |
|---|
| 212. |
Nishio S，Tsuda H，Fujiyoshi N，Ota S，Ushijima K，Sasajima Y，Kasamatsu T，Kamura T，Matsubara O. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia. Pathology-Research and Practice. 2009; 205: 331-337. |
|---|
| 213. |
Takemoto S，Ushijima K，Nakaso K，Fujiyoshi N，Kamura T. Primary adenocarcinoma of the vagina successfully treated with neoadjuvant chemotherapy consisting of paclitaxel and carboplatin. J Obstet Gynecol Res. 2009; 35: 579-583. |
|---|
| 214. |
Takemoto S，Ushijima K，Kawano K，Yamaguchi T ，Terada A，Fujiyoshi N，Nishio S，Tsuda N，Ijichi M，Kakuma T，Kage M ，Hori D，Kamura T. Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. Br J Cancer. 2009; 101: 967-972. |
|---|
| 215. |
Ohtsubo K, Sata M, Kawaguchi T, Morishige S, Takata Y, Oku E, Imamura R, Seki R, Hashiguchi M, Osaki K, Yakushiji K, Kanaji T, Yoshimoto K, Ueno T, Okamura T. Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients. Int J Hematol. 2009; 89(4): 452-9. |
|---|
| 216. |
Yamaguchi R, Tanaka M, Otsuka H, Yamaguchi M, Kaneko Y, Fukushima T, Terasaki H, Isobe S, Nakashima O, Yano H. Neuroendocrine small cell carcinoma of the breast: report of a case. Med Mol Morphol. 2009; Mar; 42(1): 58-61. |
|---|
| 217. |
Takenaka M, Tanaka M, Isobe M, Yamaguchi R, Kojiro M, Shirouzu K. Angiosarcoma of the breast with silicone granuloma: a case report. Kurume Med J. 2009; 56(1-2): 33-7. |
|---|
| 218. |
Yoshida T, Park JS, Yokosuka K, Jimbo K, Yamada K, Sato K, Takeuchi M, Yamagishi S, Nagata K. Up-regulation in receptor for advanced glycation end-products in inflammatory circumstances in bovine coccygeal intervertebral disc specimens in vitro. Spine. 2009; Jul 1;34(15): 1544-8. |
|---|
| 219. |
Mitsui Y, Yagi M, Gotoh M, Inoue H, Nagata K. J Orthop Trauma. Irreducible Galeazzi-equivalent fracture in a child: an unusual case. 2009; Jan;23(1): 76-9. |
|---|
| 220. |
Hisaoka M, Matsuyama A, Shimajiri S, Akiba J, Kusano H, Hiraoka K, Shoda T, Hashimoto H. Ossifying synovial sarcoma. Pathol Res Pract. 2009; 205(3): 195-8. |
|---|
| 221. |
Okamoto M, Azuma K, Hoshino T, Imaoka H, Ikeda J, Kinoshita T, Takamori S, Ohshima K, Edakuni N, Kato S, Iwanaga T, Aizawa H. Correlation of decreased survival and IL-18 in bone metastasis. Intern Med. 2009; 48(10): 763-73. |
|---|
| 222. |
Komatani H, Sugita Y, Arakawa F, Ohshima K, Shigemori M.. Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas. Int J Oncol. 2009 ; 34(3): 665-72. |
|---|
| 223. |
Tomita M, Toyota M, Ishikawa C, Nakazato T, Okudaira T, Matsuda T, Uchihara JN, Taira N, Ohshiro K, Senba M, Tanaka Y, Ohshima K, Saya H, Tokino T, Mori N. Overexpression of Aurora A by loss of CHFR gene expression increases the growth and survival of HTLV-1-infected T cells through enhanced NF-kappaB activity. Int J Cancer. 2009; 124(11): 2607-15. |
|---|
| 224. |
Kawano R, Karube K, Kikuchi M, Takeshita M, Tamura K, Uike N, Eto T, Ohshima K, Suzumiya J. Oncogene associated cDNA microarray analysis shows PRAME gene expression is a marker for response to anthracycline containing chemotherapy in patients with diffuse large B-cell lymphoma..J Clin Exp Hematop. 2009; 49(1): 1-7. |
|---|
| 225. |
Tanimoto K, Yakushijin Y, Fujiwara H, Otsuka M, Ohshima K, Sugita A, Sakai A, Hato T, Hasegawa H, Yasukawa M. Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma. Int J Hematol. 2009; 89(4): 497-507. |
|---|
| 226. |
Nomura Y, Kimura H, Karube K, Yoshida S, Sugita Y, Niino D, Shimizu K, Kimura Y, Aoki R, Kiyasu J, Takeuchi M, Hashikawa K, Hirose S, Ohshima K. Hepatocellular apoptosis associated with cytotoxic T/natural killer-cell infiltration in chronic active EBVinfection. PatholInt. 2009; 59(7): 438-42. |
|---|
| 227. |
Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T, Oshimi K. Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol. 2009; 27(33): 5594-600. |
|---|
| 228. |
Seki R, Ohshima K, Fujisaki T, Uike N, Kawano F, Gondo H, Makino S, Eto T, Moriuchi Y, Taguchi F, Kamimura T, Tsuda H, Ogawa R, Shimoda K, Yamashita K, Suzuki K, Suzushima H, Tsukazaki K, Higuchi M, Utsunomiya A, Iwahashi M, Imamura Y, Tamura K, Suzumiya J, Yoshida M, Abe Y, Matsumoto T, Okamura T.Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era. Cancer Sci. 2009; 100(10): 1842-7. |
|---|
| 229. |
Nomura Y, Takeuchi M, Yoshida S, Sugita Y, Niino D, Kimura Y, Shimizu K, Aoki R, Suefuji N, Hirose S, Kikuchi M, Ohshima K.. Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis. Pathol Int. 2009; 59(9): 631-5. |
|---|
| 230. |
Fujii T, Seki N, Namoto-Matsubayashi R, Takahashi H, Inoue Y, Toh U, Kage M, Shirouzu K. YB-1 prevents apoptosis via the mTOR/STAT3 pathway in HER-2-overexpressing breast cancer cells. Future Oncol. 2009; 5: 153-156. |
|---|
| 231. |
Fujii T, Takahashi H, Namoto Matsubayashi R, Inoue Y, Takenaka M, Toh U, Kage M, Yamana H, Shirouzu K. First-line treatment of metastatic breast cancer: focus on bevacizumab. Clin Med. 2009; 1: 583-593. |
|---|
| 232. |
International Consensus Group for Hepatocellular Neoplasia The International Consensus Group for Hepatocellular Neoplasia Kojiro M, Wanless IR, Alves V, Badve S, Balabaud C, Bedosa P, Bhathal P, Bioulac-Sage P, Brunt EM, Burt AD, Craig JR, Dhillon A, Ferrell L, Geller SA, Goodman ZZD, Gouw AS,Guido M, Guindi M, Hytiroglou P, Kage M, Kondo F, Kudo M, Lauwers GY, Nakano M, Paradis V, Park YN, Ougalia A, Roncalli M, Roskams T, Ruebner B, Sakamoto M, Saxena R, Theise ND, Thumg S, Taniakos D. Pathologic Diagnosis of Early Hepatocellular Carcinoma:A Report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology. 2009 Feb; 49(2): 658-664. |
|---|
| 233. |
Naito Y, Okabe Y, Kawahara A, Taira T, Ishida Y, Kaji R, Sata M, Ureshino H, Mikagi K, Kinoshita H, Yasumoto M, Kusano H, Kage M, Yano H. Usefulness of lavage cytology during endoscopic transpapillary catheterization into the gallbladder in the cytological diagnosis of gallbladder disease. Diagn Cytopathol. 2009 Jun; 7(6): 402-406. |
|---|
| 234. |
Ueki I, Kimura A, Chen HL, Yorifuji T,Mori J, Itoh S, Maruyama K, Ishige T, Takei H, Nittono H, Kurosawa T, Kage M, Matsuishi T. SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta-steroid 5beta-reducatase deficiency. J Gastroenterol Hepatol. 2009 May; 24 (5) : 776-85. |
|---|
| 235. |
AzumaK, Sasada T, Kawahara A, Hattori S, Kinoshita T, Takamori S, Ichiki M, Imamura Y, Ikeda J, Kage M, Kuwano M, Aizawa H. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation. Cancer Chemother Pharmacol. 2009 Aug; 64(3) : 565-73. |
|---|
| 236. |
Naito Y, Kinoshita H, Okabe Y, Arikawa S, Higaki K, Morimitsu Y, Yamasaki F, Suda K, Yasumoto M, Kusano H, Nakashima O, Yano H. Pathomorphologic study of undifferentiated carcinoma in seven cases: relationship between tumor and pancreatic duct epithelium. J Hepatobiliary Pancreat Surg. 2009;16(4) 478-84. |
|---|
| 237. |
Terasaki M, Tokutomi T, Shigemori M. Salvage therapy with temozolomide for recurrent or progressive high-grade gliomas refractory to ACNU [1-(4-amino-2-methyl-5-pyrimidynyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride]. Molecular Medicine Report. 2009( 2): 417-421. |
|---|
| 238. |
Fukushima S, Terasaki M, Sakata K, Miyagi N, Kato S, Sugita Y, Shigemori M. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. Brain Tumor Pathol. 2009; 26(2): 51-57. |
|---|
| 239. |
Mishima, M, Toh, U, Fukushima, T, Fukunaga, M, Nakagawa, S, Yahara, T, Shirouzu, K, Yamana, H, Seki, N. Augmentation of the clinical effect of immunotherapy using trastuzumab combined adoptive cell therapy for refractory breast cancer. Biotherapy. 2008; 22(5): 322-6. |
|---|
| 240. |
Koga M, Kai H, Egami K, Murohara T, Ikeda A, Yasuoka S, Egashira K, Matsuishi T, Kai M, Kataoka Y, Kuwano M, Imaizumi T. Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice. Biochem. Biophys. Res. Commun. 2008; 365: 279-284. |
|---|
| 241. |
Oda Y, Kohashi K, Yamamoto H, Tamiya S, Kohno K, Kuwano M, Iwamoto Y, Tajiri T, Taguchi T, and Tsuneyoshi M. Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma. Cancer Sci. 2008; 99: 726-732. |
|---|
| 242. |
Kaida H, Ishibashi M, Fujii T, Kurata S, Ogo E, Tanaka M, Hayabuchi N. Improved detection of breast cancer on FDG-PET cancer screening using breast positioning device. Ann Nucl Med. 2008; 22: 95-101. |
|---|
| 243. |
Yamaguchi R, Furusawa H, Nakahara H, Inomata M, Namba K, Tanaka M, Ohkuma K, Tayama K, Fujii T, Yano H, Kage M, Kojiro M. Clinicopathological study of invasive ductal carcinoma with large central acellular zone: Special reference to magnetic resonance imaging findings. Pathol Int. 2008; 58: 26-30. |
|---|
| 244. |
Mitsui Y, Gotoh M, Yoshida T, Hirai Y, Shinozaki T, Nakama K, Higuchi F, Nagata K. Osteoid osteoma of the proximal humerus: A misleading case. J Shoulder Elbow Surg. 2008; 17(1): e13-5. |
|---|
| 245. |
Shide K, Shimoda HK, Kumano T, Karube K, Kameda T, Takenaka K, Oku S, Abe S, Katayose KS, Kubuki Y,Kusumoto K, Hasuike S, Tahara Y, Nagata K, Matsuda T, Ohshima K, Harada M, Shimoda K Development of ET,primary myelofibrosis and PV in mice expressing JAK2 V617F. Leukemia. 2008 Jan; 22(1): 87-95. |
|---|
| 246. |
Fujii T, Yokoyama G, Takahashi H, Namoto R, Nakagawa S, Toh U, Kage M, Shirouzu K, Kuwano M. Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer. Breast Cancer. 2008; 15(1): 73-8. |
|---|
| 247. |
Fujii T, Yokoyama G, Takahashi H, Toh U, Kage M, Ono M, Shirouzu K, Kuwano M. Preclinical and clinical studies of novel breast cancer drugs targeting molecules involved in protein kinase C signaling, the putative metastasis-suppressor gene Cap43 and the Y-box binding protein-1. Curr Med Chem. 2008; 15(6): 528-37. |
|---|
| 248. |
Fujii T, Kawahara A, Basaki Y, Hattori S, Nakashima K, Nakano K, Shirouzu K, Kohno K, Yanagawa T, Yamana H, Nishio K, Ono M, Kuwano M, Kage M. Expression of HER2 and estrogen receptor a depends upon nuclear localization of Y-box binding protein-1 in human breast cancers. Cancer Res. 2008 Mar 1; 68(5): 1504-12. |
|---|
| 249. |
Yahara T, Yamaguchi R, Yokoyama G, Yamaguchi M, Nakagawa S, Toh U, Shirouzu K, Kage M, Fujii T. Adenomyoepithelioma of the breast diagnosed by a mammotome biopsy: report of a case. Surg Today. 2008; 38(2): 144-6. |
|---|
| 250. |
Kaida H, Ishibashi M, Fujii T, Kurata S, Uchida M, Baba K, Miyagawa T, Kaibara H, Kawamura S, Ogo E, Hayabuchi N. Improved breast cancer detection of prone breast fluorodeoxyglucose-PET in 118 patients. Nucl Med Commun. 2008 Oct; 29(10): 885-93. |
|---|
| 251. |
Ota S, Ushijima K, Nishio S, Takemoto S, Fujiyoshi N, Fukui A, Terada A, Kamura T. Polypoid endocervical adenomyoma of the uterus : A case report with MR imaging pathological analyses. Radiography. 2008; 14: 162-65. |
|---|
| 252. |
Nishio S, Ushijima K, Tsuda N, Takemoto S, Kawano K, Yamaguchi T, Nishida N, Kakuma T, Tsuda H, Kasamatsu T, Sasajima Y, Kage M, Kuwano M, Kamura T.Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer lett. 2008; 264: 36-43. |
|---|
| 253. |
Onda T, Matsumoto K, Shibata T, Sato A, Fukuda H, Konishi I, Kamura T, Yoshikawa H.Phase III trial upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group study JCOG 0602. Jpn J Clin Oncol. 2008; 38: 74-7. |
|---|
| 254. |
Katsumata N, Fujiwara Y, Kamura T, Nakanishi T, Hatae M, Aoki D, Tanaka K, Tsuda H, Kamiura S, Takehara K, Sugiyama T, Kigawa J, Fujiwara K, Ochiai K, Ishida R, Inagaki M, Noda K.Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcicnoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-based chemotherapy : a phase II study of the Japanese gynecologic oncology group. Jpn J Cln Oncol. 2008 NOV; 38(11): 777-85. |
|---|
| 255. |
Kanahara M, Kai H, Okamura T, Wada T, Suda K, Imaizumi T, Sagawa K. Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value. Thromb Res. 2008; 121(6): 781-5. |
|---|
| 256. |
Oku E, Kanaji T, Takata Y, Oshima K, Seki R, Morishige S, Imamura R, Ohtsubo K, Hashiguchi M, Osaki K, Yakushiji K, Yoshimoto K, Ogata H, Hamada H, Izuhara K, Sata M, Okamura T. Periostin and bone marrow fibrosis. Int J Hematol. 2008 Jul; 88(1): 57-63. |
|---|
| 257. |
Mitsuyama K, Andoh A, Masuda J, Yamasaki H, Kuwaki K, Takedatsu H, Seki R, Nishida H, Tsuruta O, Sata M. Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis. Ther Apher Dial. 2008 Aug; 12(4): 271-7. |
|---|
| 258. |
Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, Itani T, Kasugai H, Kanematsu M, Ito K, Usuki N, Shimamatsu K, Kage M, Kojiro M. Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology. 2008; 51 Suppl 1: 17-26. |
|---|
| 259. |
Suzuki F, Toyoda J, Katano Y, Sata M, Moriyama M, Imazeki F, Kage M, Seriu T, Omata M, Kumada H. Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients. J Gastroenterol Hepatol. 2008 Sep; 23(9): 1320-6. |
|---|
| 260. |
Sasada T, Azuma K, Hirai Tatsuya, Kanai Michiyuki, Takabayashi A. Prognostic significance of immediate early response gene X-1 (IEX-1) expression in pancreatic cancer. Annals of Surg Oncol. 2008; 15(2): 609-17. |
|---|
| 261. |
Okamoto M, Azuma K, Hoshino T, Imaoka H, Ikeda J, Kinoshita T, Takamori S, Ohshima K, Kato S, Iwanaga T, Aizawa H. Correlation of decreased survival and IL-18 in bone metastasis. Internal Medicine. 2009; 48(10): 763-73. |
|---|
| 262. |
Terasaki M, Eric Bouffet, Katsuki H, Fukushima S, Shigemori M. Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors. Surgical Neurology. 2008; 69(1): 46-50. |
|---|
| 263. |
Fukushima S, Kato S, Maeda M, Shigemori M. Caspase-9 pathway activation by inhibiting endogenous fibroblast growth factor signaling in human glioma cells. International Journal of Oncology. 2008; 32(2): 467-473. |
|---|
| 264. |
Sugita Y, Nakamura Y, Yamamoto M, Ogasawara S, Ohshima K, Shigemori M. Expression of KIAA 0864 protein in neuroepithelial tumors: an analysis based on the presence of monoclonal antibody HFB-16. Journal of Neurooncology. 2008; 89: 151-158. |
|---|
| 265. |
Fukushima S, Terasaki M, Shigemori M. Chordoid meningioma arising in the pineal region: a case report. Brain Tumor Pathol. 2008; 25(2): 91-95. |
|---|
| 266. |
Aoki R, Karube K, Sugita Y, Nomura Y, Shimizu K, Kimura Y, Hashikawa K, Suefuji N, Kikuchi M, Ohshima K.Distribution of malignant lymphoma in Japan: Analysis of 2260 cases, 2001-2006. Pathol Int. 2008; 58(3): 174-82. |
|---|
| 267. |
Karube K, Aoki R, Nomura Y, Yamamoto K, Yoshida S, Shimizu,K, Komatani,H,Sugita Y, Ohshima K. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: Analysis of 490 cases. Pathol Int. 2008; 58(2): 89-97. |
|---|
| 268. |
Karube K, Aoki R, Sugita Y, Yoshida S, Nomura Y, Shimizu K, Kimura Y, Hashikawa K, Takeshita M, Suzumiya J, Utsunomiya A, Kikuchi M, Ohshima K. The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma. Mod Pathol. 2008; 21(5): 617-25. |
|---|
| 269. |
Nomura Y, Sugita Y, Yoshida S, Karube K, Shimizu K, Aoki R, Hirose S, Kikuchi M, Ohshima K. Estimation of apoptosis and cell proliferation in histiocytic necrotizing lymphadenitis using immunohistochemical double staining. Pathol Int. 2008; 58(2): 98-103. |
|---|
| 270. |
Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK; CAEBV Study Group Review: Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD Pathol Int. 2008; 58(4): 209-17. |
|---|
| 271. |
Nomura Y, Karube K, Suzuki R, Ying G, Takeshita M, Hirose S, Nakamura S, Yoshino T, Kikuchi M, Ohshima K. High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients. Cancer Sci. 2008; 99(2): 246-52. |
|---|
| 272. |
Tsurusawa M, Taga T, Horikoshi Y, Ogawa A, Kikuta A, Kanegane H, Matsushita T, Hyakuna N, Shimomura Y, Ohshima K; Lymphoma Committee of Japanese Childhood Cancer and Leukemia. Favourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: a report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group. Leuk Lymphoma. 2008; 49(4): 734-9. |
|---|
| 273. |
Yamaguchi M, Nakamura N, Suzuki R, Kagami Y, Okamoto M, Ichinohasama R, Yoshino T, Suzumiya J, Murase T, Miura I, Ohshima K, Nishikori M, Tamaru J, Taniwaki M, Hirano M, Morishima Y, Ueda R, Shiku H, Nakamura S. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients. Haematologica. 2008; 93(8): 1195-202. |
|---|
| 274. |
Karube K, Ying G, Tagawa H, Niino D, Aoki R, Kimura Y, Hashikawa K, Suefuji N, Sugita Y, Nomura Y, Shimizu K, Yoshida S, Seto M, Ohshima K. BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation. Mod Pathol. 2008; 21(8): 973-8. |
|---|
| 275. |
Nomura Y, Yoshida S, Karube K, Takeshita M, Hirose S, Nakamura S, Yoshino T, Kikuchi M, Ohshima K. Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma. Cancer Sci. 2008; 99(8): 1564-9. |
|---|
| 276. |
Yoshida S, Higuchi F, Ishibashi Y, Goto M, Sugita Y, Nomura Y, Karube K, Shimizu K, Aoki R, Komatani H, Hashikawa K, Kimura Y, Nakashima M, Nagata K, Ohshima K. Down-regulation of RCAS1 and upregulation of cytotoxic T cells affects synovial proliferation and apoptosis in rheumatoid arthritis. J Rheumatol. 2008; 35(9): 1716-22. |
|---|
| 277. |
Kikuchi A, Nakamura N, Kuze T, Sasaki Y, Abe M, Ohno H, Akasaka T, Nakamura S, Ohshima K, Ando K. Characterization of de novo diffuse large B-cell lymphoma with a translocation of c-myc and immunoglobulin genes. Leuk Res. 2008; 32(8): 1176-82. |
|---|
| 278. |
Nomura Y, Lavu EK, Muta K, Niino D, Takeshita M, Hirose S, Nakamura S, Yoshino T, Kikuchi M, Ohshima K. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection. Pathol Int. 2008; 58(11): 695-700. |
|---|
| 279. |
International Peripheral T-cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008; 26(25): 4124-30. |
|---|
| 280. |
Scheeren FA, Diehl SA, Smit LA, Beaumont T, Naspetti M, Bende RJ, Blom B, Karube K, Ohshima K, van Noesel CJ, Spits H. IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood. 2008; 111(9): 4706-15. |
|---|
| 281. |
Yoshida T, Park JS, Yokosuka K, Jimbo K, Yamada K, Sato K, Nagata K. Effect of a nonprotein bioactive agent on the reduction of cyclooxygenase-2 and tumor necrosis factor-alpha in human intervertebral disc cells in vitro. J Neurosurg Spine. 2008 Nov; 9(5): 411-8. |
|---|
| 282. |
Hiraoka K, Zenmyo M, Watari K, Iguchi H, Fotovati A, Kimura YN, Hosoi F, Shoda T, Nagata K, Osada H, Ono M, Kuwano M. Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages. Cancer Sci. 2008 Aug; 99(8): 1595-602. |
|---|
| 283. |
Kometani T, Fukuda T, Kakuma T, Kawaguchi K, Tamura W, Kumazawa Y, Nagata K. Effects of α- Glucosylhesperidin, a bioactive food material, on collagen- induced arthritis in mice and rheumatoid arthritis in humans. Immunopharmacology and Immunotoxicology. 2008; 30: 117-134. |
|---|
| 284. |
Inoue H, Hiraoka K, Hoshino T, Okamoto M, Iwanaga T, Zenmyo M, Shoda T, Aizawa H, Nagata K. High levels of serum IL-18 promote cartilage loss through suppression of aggrecan synthesis. Bone. 2008 Jun; 42(6): 1102-10. |
|---|
| 285. |
Mitsui Y, Gotoh M, Nakama K, Yamada T, Higuchi F, Nagata K. Hyaluronic acid inhibits mRNA expression of proinflammatory cytokines and cyclooxygenase-2/prostaglandin E(2) production via CD44 in interleukin-1-stimulated subacromial synovial fibroblasts from patients with rotator cuff disease. J Orthop Res. 2008 Jul; 26(7): 1032-7. |
|---|
| 286. |
Yamaguchi R, Tanaka M, Kishimoto Y, Ohkuma K, Ishida M, Kojiro M. Ductal carcinoma in situ arising in a benign phyllodes tumor: report of a case. Surg Today. 2008; 38(1): 42-5. |
|---|
| 287. |
Ishii K, Ogiyama Y, Chikashige Y, Soejima S, Masuda F, Kakuma T, Hiraoka Y, Takahashi K. Heterochromatin integrity affects chromosome reorganization after centromere dysfunction. Science. 2008 Aug 22; 321 (5892): 1088-91. |
|---|
| 288. |
Furuki K, Adachi H, Enomoto M, Otsuka M, Fukami A, Kumagae S, Matsuoka H, Nanjo Y, Kakuma T, Imaizumi T. Plasma level of asymmetric dimethylarginine (ADMA) as a predictor of carotid intima-media thickness progression: six-year prospective study using carotid ultrasonography. Hypertens Res. 2008 Jun; 31(6): 1185-9. |
|---|
| 289. |
Noguchi M, Kakuma T, Suekane S, Nakashima O, Mohamed ER, Matsuoka K. A randomized clinical trial of suspension technique for improving early recovery of urinary continence after radical retropubic prostatectomy. BJU Int. 2008 Sep; 102(8): 958-63. |
|---|
| 290. |
Yamanaka R, Morii K, Shinbo Y, Homma J, Sano M, Tsuchiya N, Yajima N, Tamura T, Hondoh H, Takahashi H, Kakuma T, Tanaka R. Results of treatment of 112 cases of primary CNS lymphoma. Jpn J Clin Oncol. 2008 May; 38(5): 373-80. |
|---|
| 291. |
Matsuishi T, Nagano M, Araki Y, Tanaka Y, Iwasaki M, Yamashita Y, Nagamitsu S, Iizuka C, Ohya T, Shibuya K, Hara M, Matsuda K, Tsuda A, Kakuma T. Scale properties of the Japanese version of the Strengths and Difficulties Questionnaire (SDQ): a study of infant and school children in community samples. Brain Dev. 2008 Jun; 30(6): 410-5. |
|---|
| 292. |
Maeshiro K, Takamori S, Mifune H, Matsuo T, Kimura NY, Honda J, Shirouzu K. Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis. Surg Today. 2008; 38(2): 130-4. |
|---|
| 293. |
Mizobe T, Ogata Y, Murakami H, Akagi Y, Ishibashi N, Mori S, Sasatomi T, Shirouzu K. Efficacy of the combined use of bevacizumab and irinotecan as a postoperative adjuvant chemotherapy in colon carcinoma. Oncol Rep. 2008 Sep; 20(3): 517-23. |
|---|
| 294. |
Chitose SI, Umeno H, Hamakawa S, Nakashima T, Shoji H. Unilateral associated laryngeal paralysis due to varicella-zoster virus: virus antibody testing and videofluoroscopic findings. J Laryngol Otol. 2008 Feb; 122(2): 170-6. |
|---|
| 295. |
Sato K, Miyajima Y, Izumaru S, Nakashima T. Cultured stellate cells in human vocal fold mucosa. J Laryngol Otol. 2008 Dec; 122(12): 1339-42. |
|---|
| 296. |
Sato K, Nakashima T. Effect of irradiation on the human laryngeal glands. Ann Otol Rhinol Laryngol. 2008 Oct; 117(10): 734-9. |
|---|
| 297. |
Sato K, Shirouzu H, Nakashima T. Irradiated macula flava in the human vocal fold mucosa. Am J Otolaryngol. 2008 Sep-Oct; 29(5): 312-8. |
|---|
| 298. |
Umeno H, Chitose S, Sato K, Nakashima T. Efficacy of additional injection laryngoplasty after framework surgery. Ann Otol Rhinol Laryngol. 2008 Jan; 117(1): 5-10. |
|---|
| 299. |
Yamamoto H, Sekine I, Yamada K, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T. Gender differences in treatment outcomes among patients with non-small cell lung cancer given a combination of carboplatin and paclitaxel. Oncology. 2008; 75: 169-174. |
|---|
| 300. |
Shimizu T, Yamamoto N, Yamada Y, Fujisaka Y, Yamada K, Fujiwara Y, Takayama K, Tokudome T, Klimovsky J, Tamura T. Phase I clinical and pharmacokinetic study of 3-weekly, 3-h infusion of ixabepilone (BMS-247550), an epothilone B analog, in Japanese patients with refractory solid tumors. Cancer Chemother Pharmacol. 2008; 61: 751-758. |
|---|
| 301. |
Goto Y, Sekine I, Yamada K, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T. Influence of previous chemotherapy on the efficacy of subsequent docetaxel th3erapy in advanced non-small cell lung cancer patients. J Thorac Oncol. 2008; 3: 412-416. |
|---|
| 302. |
Toh U, Fujii T, Mishima M, Imaizumi T, Koga A, Yano S, Shirouzu K, Yahara T, Yamana H. Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer. Gan To Kagaku Ryoho. 2007; 34: 1931-3. |
|---|
| 303. |
Shiozaki H, Fujiwara Y, Hirai T, Matsubara H, Mori M, Nakamura T, Nakanishi Y, Natsugoe S, Noguchi T, Ozawa S, Shimada Y, Udagawa S, Yamana H, Yano M, Yasuda T. Clinical significance of immunohistochemically detected lymph node micrometastasis in patients with histologically node-negative esophageal carcinoma: a multi-institutional study. Esophagus. 2007; 4(1): 35-39. |
|---|
| 304. |
Nagamatsu Y, Maeshiro K, Kashihara M, Iwasaki Y, Shima I, Yamana H, Shirouzu K. Selection of pulmonaru resection procedures to avoid postoperative complications. Surg Today. 2007; 37(3): 202-206. |
|---|
| 305. |
Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T, Hatae M, Kodama S, Saito T, Terakawa N, Yaegashi N, Hiura M, Sakamoto A, Tsuda H, Fukunaga M, Kamura T. Fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women: a multicenter phase II study. J Clin Oncol. 2007; 25(19); 2798-803. |
|---|
| 306. |
Yokosuka K, Park JS, Jimbo K, Yoshida T, Yamada K, Sato K, Takeuchi M, Yamagishi S, Nagata K. Immunohistochemical demonstration of advanced glycation end products and the effects of advanced glycation end products in ossified ligament tissues in vitro. Spine. 2007 May 15; 32(11): E337-9. |
|---|
| 307. |
Karube K, Guo Y, Suzumiya J, Sugita Y, Nomura Y, Yamamoto K, Shimizu K, Yoshida S, Komatani H, Takeshita M, Kikuchi M, Nakamura N, Takasu O, Arakawa F, Tagawa H, Seto M, Ohshima K. CD10(-)MUM1(+) follicular lymphoma lacks BCL2 translocation and shows characteristic biological and clinical features. Blood. 2007; 109: 3076-9. |
|---|
| 308. |
Sagara Y, Inoue Y, Ohshima K, Kojima E, Utsunomiya A, Tsujimura M, Shiraki H, Kashiwagi S. Antibody to the central region of human T-lymphotropic virus type 1 gp46 is associated with the progression of adult T-cell leukemia. Cancer Sci. 2007; 98: 240-5. |
|---|
| 309. |
Naito Y, kinosahita H, Okabe Y, Kawahara R, Sakai T, Suga H, Arikawa S, Oshima K. Kojiro M. CD56 (NCAM) expression in pancreatic carcinoma and the surrounding pancreatic tissue. Kurume Medical J. 2006; 53: 59-62. |
|---|
| 310. |
Kaneyuki U, Ueda S, Yamagishi S, Kato S, Fujimura T, Shibata R, Hayashida A, Yoshimura J, Kojiro M, Oshima K, Okuda S. Pitavastatin inhibits lysophosphatidic acid-induced prolifera-tion and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. Vascul Pharmacol. 2007; 46: 286-92. |
|---|
| 311. |
Guo Y, Karube K, Kawano R, Suzumiya J, Takeshita M, Kikuchi M, Huang GS, Li Q, Ohshima K. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression. Pathol Int. 2007; 57: 148-52. |
|---|
| 312. |
Karube K, Suzumiya J, Okamoto M, Takeshita M, Maeda K, Sakaguchi M, Inada T, Tsushima H, Kikuchi M, Ohshima K. Adult T-cell lymphoma/leukemia with angioimmunoblastic T-cell lymphomalike features: Report of 11 cases. Am J Surg Pathol. 2007; 31: 216-23. |
|---|
| 313. |
Kawahara A, Harada H, Akiba J, Yokoyama T, Kage M. Fine-needle aspiration cytology of basal cell adenoma of the parotid gland: characteristic cytological features and diagnostic pitfalls. Diagn Cytopathol. 2007 Feb; 35(2): 85-90. |
|---|
| 314. |
Shimakage M, Inoue N, Ohshima K, Kawahara K, Oka T, Yasui K, Matsumoto K, Inoue H, Watari A, Higashiyama S, Yutsudo M.Downregulation of drs mRNA expression is associated with the progression of adult T-cell leukemia/lymphoma. Int J Cancer. 2006; 119: 1648-53. |
|---|
| 315. |
Basaki Y, Hosoi F, Oda Y, Fotovati A, Maruyama Y, Oie S, Ono M, Izumi H, Kohno K, Shimoyama T, Nishio K, Kuwano M. Akt-dependent nuclear localisation of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene. 2007; 26: 2736-2746. |
|---|
| 316. |
Oda Y, Ohishi Y, Basaki Y, Kobayashi H, Hirakawa T, Wake N, Ono M, Nishio K, Kuwano M, Tsuneyoshi M. Prognostic inmlication of nuclear localization of the Y-box-binding protein-1 and CXC4 expression in ovarian cancer: Their correlation with activated Akt, LRP/MVP and P-glycoprotein expression. Cancer Sci. 2007; 98: 1020-1026. |
|---|
| 317. |
Ohishi Y, Oda Y, Basaki Y, Kobayashi H, Wake N, Kuwano M, Tsuneyoshi M. Expression of beta-tubulin isotypes in human primary ovarian carcinoma. Gynecol. Oncol. 2007; 105: 586-592. |
|---|
| 318. |
Nakagawa M, Oda Y, Eguchi T, Aishima S, Yao T, Hosoi F, Basaki Y, Ono M., Kuwano M, Tanaka M, Tsuneyoshi M. Expression profile of class I histone deacetylases in human cancer tissues. Oncology Rep. 2007; 18: 769-774. |
|---|
| 319. |
Fukahori S, Yano H, Tsuneoka M, Tanaka Y, Yagi M, Kuwano M, Tajiri T, Taguchi T, Tsuneyoshi M, Kojiro M. Immunohistochemical expression of Cap43 and Mina53 proteins in neuroblastoma. J Pediatric Surgery. 2007; 42: 1831-1840. |
|---|
| 320. |
Kimura Y, Watari K, Fotovati A, Hosoi F, Yasumoto K, Izumi H, Kohno K, Umezawa K, Iguchi H, Shirouzu K, Takamori S, Kuwano M Ono M. Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Sci. 2007; 98: 2009-2018. |
|---|
| 321. |
Nakao S, Hata Y, Miura M, Noda K, Kimura Y, Kawahara S, Kita T, Hisatomi T, Nakazawa T, Jin Y, Dana R, Kuwano M, Ono M, Ishibashi T, Hafezi-Moghadam A. Dexamethasone inhibits IL-1β-induced corneal neovascularization: role of NF-kB-activated stromal cells in inflammatory angiogenesis. Am. J. Path. 2007; 171: 1058-1065. |
|---|
| 322. |
Oie S, Ono M, Fukushima H, Hosoi F, Yano H, Maruyama Y, Kojiro M, Terada T, Hirano K, Kuwano M, Yamada Y. Alteration of dihydropyrimidine dehydrogenase expression by interferon-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells. Molec. Cancer Therapeut. 2007; 6: 2310-2318. |
|---|
| 323. |
Hiraoka K, Zenmyo M, Watari K, Iguchi H, Fotovati A, Kimura Y, Hosoi F, Shoda, T, Nagata K, Osada H, Ono M, and Kuwano M. Inhibition of bone and muscle metastases of lung cancer cells by decrease in the number of monocytes/macrophages. Cancer Sci. 2008; 99(8): 1595-602. |
|---|
| 324. |
Tanaka T, Fujita H, Sueyoshi S, Tanaka Y, Sasahara H, Nori N, Nagano T, Yamana H, Shirouzu K. Second-line combination chemotherapy with docetaxel for cisplatin-pretreated refractory metastatic esophageal cancer: A preliminary report of initial experience. Chemotherapy. 2007; 53(6): 449-453. |
|---|
| 325. |
Nagamatsu Y, Maeshiro K, Kimura NY, Nishi T, Shima I, Yamana H, Shirouzu K. Long-term recovery of exercise capacity and pulmonary function after lobectomy. J Thorac Cardiovasc Surg. 2007; 134(5): 1273- -1278. |
|---|
| 326. |
Kono R, Fujimoto K, Terasaki H, Muller NL, Kato S, Sadohara J, Hayabuchi N, Takamori S: Dynamic MR imaging of solitary pulmonary nodules. Comparison of enhancement patterns between small peripheral lung cancers and benign lesions in 202 patients. Am J Roentgenol. 2007; 188(1): 26-36. |
|---|
| 327. |
Fujimoto K, Takamori S, Yano H, Sadohara J, Matsuo T, Terazaki Y, Ishibashi M, Hayabuchi N. Focal cholesterol granuloma in the anterior mediastinum: [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and magnetic resonance imaging findings. J Thorac Oncol. 2007; 2(11): 1054-1056. |
|---|
| 328. |
Motoshi Miyagi, Keishiro Aoyagi, Seiya Kato, Kazuo Shirouzu. The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer. 2007; 12: 17-24. |
|---|
| 329. |
Naoki Mori, Hiromasa Fujita, Susumu Sueyoshi, Yuko Aoyama, Takashi Yanagawa Kazuo Shirouzu. Helicobacter pylori infection influences the acidity in the gastric tube as an esophageal substiute after esophagectomy. Diseases of the Esophagus. 2007; 20: 333?340. |
|---|
| 330. |
Hirotoshi Kobayashi, Hidetaka Mochizuki, Kenichi Sugihara, Takayuki Morita, Kenjiro Kotake, Tatuno Teramoto, Shingo Kameoka, Yukio Saito, Keiichi Takahashi, Kazuo Hase, Masatoshi Oya, Kotarou Maeda, Takashi Hirai, Masao Kameyama, Kazuo Shirouzu, Tetsuichiro Muto. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: A multicenter study. Surgery. 2007; 141: 167-75. |
|---|
| 331. |
Ryuichi Kawahara, Masaharu Odo, Hisafumi Kinoshita, Kazuo Shirouzu, Shigeaki Aoyagi. Analysis of hTERT mRNA expression in biliary tract andpancreatic cancer. J Hepatobiliary Pancreat Surg Springer. 2007;14: 189 |
|---|
| 332. |
Yutaka Ogata,Teruo Sasatomi, Shinjiro Mori, Keiko Matono, Nobuya Ishibashi Yoshito Akagi, Takanaru Fukushima, Hidetsugu Murakami, Masataka Ushijima, Kazuo Shirouzu. Significance of Thymidine Phosporylase in Metronomic Chemotherapy using CPT-11 and Doxifluridine for Advanced Colorectal Carcinoma. Anticancer Research. 2007; 27: 2605-2612. |
|---|
| 333. |
Hiromasa Fujita, Takashi Aikou, Masahiko Tsurumaru, Misao Yoshida, Tadakazu Shimoda, Tatsuyuki Kawano, Atsushi Otsu, Yuji Tachimori, Yutaka Shimada, Harushi Udagawa, Soji Ozawa, Hisahiro Matsubara, Kenji Nemoto. A new N category for cancer in the esohagogastric junction based on Iymph node compartrments. Japan Esophageal Society and Springer. 2007; 4: 103-110. |
|---|
| 334. |
Koich Azuma, Yoshihiro Komohara, Tetsuro Sasada, Yasuhiro Terazaki, Jiro Ikeda Tomoaki Hoshino, Kyogo Itoh, Akira Yamada and Hisamichi Aizawa. Excision repair cross-complementation group1 predicts progression-fre and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Science. 2007; 98: 1336-43. |
|---|
| 335. |
Kishimoto Y, Araki Y, Ogata Y, Shirouzu K. Functuonal outcome after sphincter excision for ultralow rectal cancer. Int Surgery. 2007; 92: 43-53. |
|---|
| 336. |
Teruhisa Kazui, Hiroaki Osada, HIromasa Fujita. An attempt to analyze The relation between hospital volume and clinical outcome. General Thoracic and Cardiovascular Surgery. 2007; 55: 483-492. |
|---|
| 337. |
Keisuke Miwa, Yasumi Araki, Nobuya Ishibashi, Kazuo Shirouzu. Experimental Study of Composix Mesh for Ventral Hernia. Int Surg. 2007; 92: 192-194. |
|---|
| 338. |
Nago T, Umezu Y, Shiba N, Matsuse H, Maeda T, Tagawa Y, Nagata K, Basford JR. Muscle maintenance by volitional contraction against applied electrical stimulation. Kurume Med J. 2007; 54(1-2): 35-40. |
|---|
| 339. |
Kanazawa T, Sannomiya T, Okawa T, Gotoh M, Higuchi F, Inoue A, Nagata K. Simple limbectomy dose not affect the growth of the acetabulum: an experimental study. Kurume Med J. 2007; 54(1-2): 31-4. |
|---|
| 340. |
Yamada T, Gotoh M, Nakama K, Mitsui Y, Higuchi F, Nagata K. Effects of Hyaluronan on Cell Proliferation and mRNA Expression of Procollagens {alpha}1 (I) and {alpha}1 (III) in Tendon-Derived Fibroblasts From Patients With Rotator Cuff Disease: An In Vitro Study. Am J Sports Med. 2007; 35(11): 1870-6. |
|---|
| 341. |
Nishio S, Sugiyama T, Shouji T, Yoshizaki A, Kitagawa R, Ushijima K, Kamura T. Pilot study evaluating the efficacy and toxicity of irinotecan plus oral etoposide for platinum-and taxane-resisitant epithelial ovarian cancer. Gynecol Oncol. 2007; 106: 342-347. |
|---|
| 342. |
Kawano K, Ushijima K, Fujimoto T, Komai K, Kamura T. Peptide YY producing strumal carcinoid of the ovary as the cause of severe constipation with contralateral epithelial ovarian cancer. J Obstet Gynaecol Res. 2007; 33: 392-396. |
|---|
| 343. |
Matsuo G, Ushijima K, Shinagawa A, Takahashi S, Fujiyoshi N, Takemoto S, Terada A, Fukui A, Kamura T. GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity:an experiment using a rat model. Kurume Med J. 2007; 54: 25-29. |
|---|
| 344. |
Ushijima K. Management of retroperitoneal lymph nodes in the treatment of ovarian cancer. Int J Oncol. 2007; 12: 181-186. |
|---|
| 345. |
Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, Yamamoto K, Horiuchi H, Takada K, Ohshima K, Nakamura S, Kinukawa N, Oshimi K, Kawa K..Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007; 86: 58-65. |
|---|
| 346. |
Koida S, Tsukasaki K, Tsuchiya T, Harasawa H, Fukushima T, Yamada Y, Ohshima K, Kamihira S, Kikuchi M,Tomonaga M. Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis. Haematologica. 2007; 92(3): e37-40. |
|---|
| 347. |
Sugita Y, Komatani H, Ohshima K, Shigemori M, Nakashima A. Expression of cyclooxygenase-2 and vascular endothelial growth factor in primary central nervous system lymphomas. Oncol Rep. 2007; 18: 617-22. |
|---|
| 348. |
Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N, Fukata M, Miyamoto T, Lyons B, Ohshima K, Uchida N, Taniguchi S, Ohara O, Akashi K, Harada M, Shultz LD. Chemotherapy-resistant human AML stem cells home to and engraft within thebone-marrow endosteal region. Nat Biotechnol. 2007 Nov; 25(11):1315-21. |
|---|
| 349. |
Oyama T, Yamamoto K, Asano N, Oshiro A, Suzuki R, Kagami Y, Morishima Y, Takeuchi K, Izumo T, Mori S, Ohshima K, Suzumiya J, Nakamura N, Abe M, Ichimura K, Sato Y, Yoshino T, Naoe T, Shimoyama Y, Kamiya Y, Kinoshita T, Nakamura S. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res. 2007; 13(17): 5124-32. |
|---|
| 350. |
Shimizu K, Karube K, Arakawa F, Nomura Y, Komatani H, Yamamoto K, Yoshida S, Aoki R, Sugita Y, Takeshita M, Ohshima K. Upregulation of CC chemokine ligand 18 and downregulation of CX3C chemokine receptor 1 expression inhuman T-cell leukemia virus type 1-associated lymph node lesions: Results of chemokine and chemokine receptor DNA chip analysis. Cancer Sci. 2007; 98(12): 1875-80. |
|---|
| 351. |
Ohshima K. Pathological features of diseases associated with human T-cell leukemia virus type I. Cancer Sci. 2007; Jun; 98(6): 772-8. |
|---|
| 352. |
Yakushijin Y, Shikata H, Kito K, Ohshima K, Kojima K, Hato T, Hasegawa H, Yasukawa M. Follicular dendritic cell tumor as an unknown primary tumor. Int J Clin Oncol. 2007; 12: 56-8. |
|---|
| 353. |
Toita N, Hatano N, Ono S, Yamada M, Kobayashi R, Kobayashi I, Kawamura N, Okano M, Satoh A, Nakagawa A, Ohshima K, Shindoh M, Takami T, Kobayashi K, Ariga T. Epstein-Barr virus-associated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. Am J Med Genet A. 2007; 143: 742-5. |
|---|
| 354. |
Higuchi M, Muta T, Karube KN, Eto T, Yamano Y, Ohshima K. Epstein-Barr virus-positive blastoid variant of mantle cell lymphoma in an adult with recurrent infectious mononucleosis-like symptoms: a case report. Int J Hematol. 2007; 85: 219-22. |
|---|
| 355. |
Suehiro Y,Tachikawa Y,Abe Y, Ohshima K,, Muta K, Tani K Epithelioid hemangioendothelioma presenting with severe myelofibrosis and a high serum hyaluronan level. Eur J Haematol. 2007; 79: 349-353. |
|---|
| 356. |
Seki R, Okamura T, Ide T, Kage M, Sata M, Uyesaka N, Maruyama, T. Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability. Journal of Physiological Sciences; 2007; 57(1): 43-49. |
|---|
| 357. |
Tanikawa K, Kage M, Komuta M, Nakashima O, Yano H, Yatsuhashi, H., Kojiro, M. Pathological analysis of oxyphilic granular hepatocytes and hepatocellular mitochondria in chronic hepatitis C. Hepatology Research. 2007; 37(6): 425-432. |
|---|
| 358. |
Kage M. Pathology of autoimmune liver disease in children. Hepatology Research. 2007; 37: S502-508. |
|---|
| 359. |
Kuwahara R, Saitsu H, Abe M, Takata A, Tanaka K, Hino T, Ide T, Kuromatsu R, Tanikawa K, Kage M, Kumashiro R, Sata M. Successful treatment with corticosteroid and lamivudine for autoimmune hepatitis in a patient with asymptomatic HBV infection. Digestive Diseases and Sciences. 2007; 52(4): 908-913. |
|---|
| 360. |
Fukahori S. Tsuru T, Tanikawa K, Akiyoshi K, Asagiri K, Tanaka Y, Kage M, Kojiro, M., Mizote, H., Yagi, M. Mesenchymal hamartoma of the liver accompanied by a daughter nodule: Report of a case. Surgery Today. 2007; 37(9): 811-816. |
|---|
| 361. |
Kashiwagi, Y., Kawashima, H., Ioi, H. , Amaha, M., Nishimata, S., Takekuma, K., Hoshika, A., Tanabe, Y., Nagae, I., Kage, M. Biliary atresia with cartilage formation. Pediatrics International. 2007; 49(5): 683-685. |
|---|
| 362. |
Shimizu T, Sekine I, Sumi M, Ito Y, Yamada K, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older. Jpn J Clin Oncol 2007; 37: 181-185. |
|---|
| 363. |
Sekine I, Yamada K, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T. Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity. Cancer Sci. 2007; 98: 1408-1412. |
|---|
| 364. |
Fujiwara Y, Sekine I, Tsuta K, Ohe Y, Kunitoh H, Yamamoto N, Nokihara H, Yamada K, Tamura T. Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung. Jpn J Clin Oncol. 2007; 37: 482-486. |
|---|
| 365. |
Fujiwara Y, Sekine I, Ohe Y, Kunitoh H, Yamamoto N, Nokihara H, Simmyo Y, Fukui T, Yamada K, Tamura T. Serum total bilirubin as a predictive factor for severe neutropenia in lung cancer patients treated with cisplatin and irinotecan. Jpn J Clin Oncol. 2007; 37: 358-364. |
|---|
| 366. |
Terasaki M, Abe T, Miyagi N, Ogo E, Shigemori M. Feasiblity and response to 1-(4-amino-2-methyl-5-pyrimidynyl)methyl-3-(2-chloroethyl)-3-nitrosoureahydrochloride chemotherapy with pre-treated procarbazine for erderly patients with newly diagnosed glioblastoma. J Neurooncol. 2007 81; 265-269. |
|---|
| 367. |
Terasaki M, Ogo E, Fukushima S, Sakata K, Miyagi N, Abe T, Shigemori M. Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial. Surg Neurol. 2007; 68; 250-254. |
|---|
